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The effect of lactate on myometrial contractility 
Jacqui-Ann Hanley 
Abstract 
Strong coordinated uterine contractions are needed in labour and the mechanisms that 
govern this are well understood. However when these contractions are weak or 
uncoordinated, labour cannot progress normally. This is termed dysfunctional labour and it 
accounts for ~20% of all caesarean sections (CS) in the UK. Currently the only treatment 
available is oxytocin, however this does not reduce the incidence of CS. Lactate is 
significantly increased in myometrial capillary blood during dystocia suggesting it may be 
impairing force production, but there are no functional data on the effect of lactate on 
myometrial contractility. 
 The aims of this work were to a) investigate the effect of lactate and its mechanism 
of action on myometrial contractility using both human myometrium and an animal model. 
The effect on spontaneous and oxytocin-stimulated contractions was also examined and b) 
investigate the presence of lactate transporters MCT-1 and MCT-4 in rat myometrium 
throughout gestation and in human myometrium was looked at. 
Lactate, dose-dependently and significantly, decreased spontaneous contractility in 
rat and human myometrium. Weak acids butyrate, propionate, and pyruvate also 
significantly reduced contractions in a dose-dependent manner. The effects of lactate were 
reduced in the presence of oxytocin but not abolished.  The effect on pregnant myometrium 
was greater than in non-pregnant, and was shown to increase towards term in the animal 
model. In labouring myometrium, there was little effect of lactate on contractility. Using the 
animal model to investigate lactate’s mechanism in the myometrium, tissue strips were 
loaded with either Indo-1 AM (a Ca2+ sensitive indicator) or Carboxy SNARF-AM (a pH 
sensitive indicator). Lactate inhibited Ca2+ transients and had little effect on force when a 
Ca2+ channel agonist was present. Lactate decreased pHi in a dose dependent manner and 
this drop in pHi was reduced when the tissue was stimulated by oxytocin or in labour. Both 
MCT-1 and MCT-4 were found to be present in rat and human myometrium, with MCT-1 at 
a higher amount in pregnant myometrium. 
From this work I have shown that lactate in the physiological range potently 
decreases spontaneous contractility in both rat and human myometrium. The effects of 
lactate were reduced in the presence of oxytocin or labour but still produced significant 
decreases and this may be due the difference in alteration of pHi. Other weak acids produce 
similar effects to lactate suggesting its mechanism of action is not via lactate’s role in 
metabolism. Lactate inhibited Ca2+ transients, which could be due to a fall of pHi, as it has 
previously been demonstrated that intracellular acidification decreases Ca2+ current through 
L-type Ca2+ channels. The difference in MCT-1 and MCT-4 expression between non-pregnant 
and pregnant tissue may indicate a role in labour. I suggest that differences in myometrial 
lactate in women can lead to accumulation of extracellular lactate, which as we have shown, 
will reduce myometrial contractions and could therefore contribute to dysfunctional labour.  
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Chapter 1 
Introduction 
1.1 Uterus 
1.1.1 Anatomy 
The human uterus is a pear-shaped muscular organ, which is hollow and thick-walled. In 
nulliparous women of reproductive age the uterine wall is 1.5cm thick. It is small, 7.5cm 
long with a maximum diameter of 5cm. The non-pregnant uterus weighs around 30-40g but 
in pregnancy, it can increase to 1kg at term (Gray 2000). In its normal position the uterus 
bends anteriorly near its base. The broad ligament and three pairs of suspensory ligaments 
stabilise it in position and limits its range of movement. 
There are two regions of the uterus - the body forming the upper two-thirds of the organ 
and the cervix, which is narrower and more cylindrical in shape. 
The uterine body or the ‘corpus’ is the largest portion of the uterus. The fundus is the 
rounded portion of body and the body ends at a constriction known as ‘isthmus’ (Figure 
1.1). The cervix is the inferior portion that extends from the isthmus to the vagina. 
The uterus receives blood from uterine arteries, which arise from branches of the internal 
iliac arteries, and from ovarian arteries which arise from the abdominal aorta inferior to the 
renal arteries. The uterus is extensively interconnected so as to have a reliable blood flow.  
The uterus is a myogenic organ. The smooth muscle is able to contract without input 
hormonal or nervous input (Wray 1993). The basic processes of excitation and contraction 
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reside in the smooth muscle cells (Wray et al. 2001). Hormones can affect contraction, they 
can be powerful modulators and are used clinical to induce and augment labour. 
The uterus has a thick outer fibromuscular layer called the myometrium. There is a thin 
inner glandular layer called the endometrium. The perimetrium is the “layer of peritoneum 
that covers the uterus except at the sides where it extends to form the broad ligaments” 
(Gray 2000). 
1.1.2 Rat uterus 
The uterus of the Wistar rat ‘Rattus norvegicus’ is a duplex uterus which enables multiple 
offspring. The ovaries are located at the distal ends of the horns and are connected to the 
uterus by oviducts. Both horns lead to a shared vagina (Figure 1.2). The anatomy at the 
myometrial level is similar to human tissue. 
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Figure  1.1 Anatomy of the human uterus
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Figure  1.2 Anatomy of the rat uterus
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1.2 Myometrium 
1.2.1 Overview 
The myometrium accounts for 90% of mass of uterus (the endometrium accounts for 10%). 
It is a smooth muscle with longitudinal, circular and oblique muscle layers in women, which 
provides force to expel the fetus out of uterus during labour.  
The myometrium has 4 distinct layers: 
1. Internal layer- ‘stratum submucosum’ composed mostly of longitudinal and some 
oblique smooth muscle. Oblique muscle runs ‘criss cross’ and constrict blood vessels 
when the uterus contracts. 
2. External to that ‘stratum vasculare’ zone rich in blood vessels and longitudinal 
muscle. 
3. ‘stratum supravasculare’ predominately circular muscle. 
4. Thin longitudinal layer ‘stratum subserosum’ adjacent to perimetrium. 
Contraction of the myometrium shortens the uterus and decreases the size of the lumen. 
During pregnancy there is an increase in vascularity and tissue fluid of the myometrium, 
together with myometrial growth. Cell proliferation is the cause of the increased size from 
the nulliparous to the parous uterus. This increased growth is driven by a combination of 
mechanical stretching and oestrogen stimulation. The smooth muscle mass of myometrium 
increases throughout pregnancy by hypertrophy with some hyperplasia in early pregnancy. 
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1.2.2 Myometrial machinery 
Myometrial cells are elongated and fusiform with tapering ends, which is typical of most 
visceral smooth muscle. Cells are varied in length and 5 to 10µm diameter. Up to 90% of 
their volume is filled with myofilaments, with the remaining space taken up by the nucleus, 
sarcoplasmic reticulum and mitochondria. 
The myometrial force apparatus is made up of thick and thin filaments- called myosin and 
actin respectively (Gabella 1984). 
Myosin filaments measure 15nm in diameter and are more heterogeneous in diameter and 
longer than that of myosin in striated muscle. Smooth muscle myosin is 470kDa in size, with 
two globular head groups joined by 150nm long tail. Associated with each head are 20 and 
17kDa chains. The 20kDa chain is involved in calcium dependent regulation of contraction 
(see Chapter 1.3.1). 
In the myometrium there are thin filaments, of which actin is a major component. Actin is 
circular and 7nm in diameter. It is organised into orderly packed bundles with a lattice-like 
appearance. Actin monomers organise as double-stranded helix to form filamentous actin.  
Intermediate filaments are not directly involved in contractile processes. They form a 
cytoskeleton to support the myofilaments. These are composed mainly of desmin (Leoni, 
Carli & Halliday 1990). 
The pattern of myofilaments in the myometrium does not constitute well-defined myofibrils 
and sarcomeres as found in striated muscle. Myosin and actin filaments do not run parallel 
to each other. There are also more thin than thick filaments found in smooth muscle 
compared to striated muscle (Cavaille 1985). 
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1.2.3 Resting membrane potential 
Resting membrane potential in term pregnant human myometrium is around -40 to -70mV 
(Nakajima 1971) and this is similar in rat myometrium (Kuriyama & Suzuki 1976). The resting 
membrane potential becomes more negative towards mid-pregnancy (-60mV) and increases 
near term and parturition to -45 mV (Anderson, Kawarabayashi & Marshall 1981; Kuriyama 
& Suzuki 1976). 
Depolarisation of the plasma membrane is caused by voltage and time dependant changes 
in membrane ion permeabilities. In smooth muscle there is an influx of Ca2+ which is caused 
by the activation of voltage-gated Ca2+ channels. This inward current occurs when the 
threshold of -40mV is reached and gives rise to the action potential. The time course for the 
action potential is highly variable and dependent on species, reproductive state and the 
region of measurement (Parkington & Coleman 1988). The peak of this upstroke is reached 
in 10ms and is followed by repolarisation. This is due to inactivation of voltage-, time- and 
calcium-activated channels and the activation of fast (voltage-gated) and slow (calcium-
activated) K+ channels, allowing the outward K+ current (Figure 1.3). 
Frequency, amplitude and duration of contractions are determined by the frequency of 
electrical bursts, number of cells active during bursts and the duration of bursts. Gap 
junctions provide the connection between cells to allow electrical coupling and increase 
conductance. They are composed of connexion proteins and grouping provides channels of 
low electrical resistance between cells. There channels are low in number throughout 
pregnancy, which decreases the coupling and conductance of cells. This favours quiescence.  
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Figure  1.3 Membrane potential, Ca2+ flux and muscle contraction
Action 
potential
Muscle 
cell
Contraction
Ca2+
K+
Ca2+
Na+
10-7M 10-5M 10-7M
10-3M
-45mV
-70mV
0mV
25 
 
However at term, junctions increase and allow the coordination of cells for contractions. 
Gap junctions are controlled by oestrogen and progesterone. 
The myometrium is a spontaneously active and highly excitable muscle (The Uterus  1994). 
Pacemaker cells are thought to be responsible for the spontaneous initiation of activity. 
They are autonomously active. Action potentials arise in pacemaker cells and are 
transmitted over the whole organ. These cells are not localised to a specific region and it has 
been said that "all muscle cells are capable of becoming pacemakers" (The Uterus  1994). 
Although these cells have not been characterised in the myometrium, it is thought that they 
are similar to ICC cells as found in the gut (Duquette & Wray 2001). Stretching of the uterus 
has also been shown to induce activity (Lodge & Sproat 1981). 
 
1.2.4 Ca2+ channels 
The main function of Ca2+ channels in the myometrium is to provide a route of entry for Ca2+ 
down its concentration gradient into the myometrial cells for contraction. There are two 
types of calcium channel: Voltage-gated (VCCC) and ligand-gated channels. Voltage-gated 
channels divided into three main groups: Cav1 (L-type) Cav2 (P-N-and R-type) and Cav3 (T-
type) (Ertel et al. 2000; Lipscombe 2002). L-type and T-type channels have been identified in 
the myometrium (Lee, Ahn & Lee 2009; Wray et al. 2003; Young, Smith & McLaren 1993). T-
type currents have been recorded in human myometrium; they produce transient, low-
voltage currents which are implicated in action potential initiation and modulation for 
spontaneous Ca2+ transient frequency (Lee, Ahn & Lee 2009). 
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-L-type Ca2+ channels  
L-type Ca2+ channels are the main type of VCCC in the uterus. They are crucial for excitation-
coupling (Lipscombe, Helton & Xu 2004). These channels produce high voltage, long lasting 
currents through Ca1.2 channels, which is the primary calcium entry route. L-type channels 
account for majority of calcium current measured in the myometrium (Shmygol et al. 2007) 
and main route for Ca2+ entry in the myometrium. Membrane depolarisation is key for 
activation of these channels. L-type Ca2+ channels are also subject to hormonal control. 
Auxiliary subunits allow modulation of these channels via protein-kinase A-,C- and G-
mediated phosphorylation (Shmygol et al. 2007). The levels of these channels alter 
throughout gestation suggesting a role in parturition (Young, Smith & McLaren 1993). 
 
1.2.5 K+ channels 
Potassium efflux from the myometrium results in membrane repolarisation and this is 
responsible for maintaining the resting membrane potential (Brainard, Korovkina & England 
2007). They also contribute to uterine quiescence during pregnancy. 
-Ca2+-activated potassium channels 
There are three subclasses of Ca2+-activated potassium channels: large (BK) intermediate 
(IK) and small (SK) conductance channels (Noble et al. 2009). These channels are activated 
when [Ca2+]i is elevated (BlatzMagleby1987). BKCa channels are the most extensively 
studied in the uterus due to their abundance and significant current (Brainard, Korovkina & 
England 2007). Their expression has been shown to decrease at the time of parturition 
indicating a role in the switch from quiescence to labour (Noble et al. 2009). However BKCa 
channels have little functional effect in rat uterus (Aaronson et al. 2006). Hormones can 
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regulate myometrial tone via these channels- sex hormones and hormones of the 
hypothalamus-pituitary-adrenal axis (Benkusky et al. 2002). 
SK channels recently been shown to be expressed in myometrium (Noble et al. 
2010). They have a similar structure to voltage gated potassium channels (Maylie et al. 
2004) and contribute to outward current and regulate membrane potential. SK channels 
appear to contribute more to quiescence that BK channels. 
-Voltage-gated K+ channels 
Voltage-gated K+ (Kv) channels are widely expressed and also contribute to resting 
membrane potential in the myometrium. K+ efflux occurs via these channels, in response to 
depolarisation which induces repolarisation of the membrane. Two types of Kv current have 
been identified in human myometrium: delayed rectifiers and rapidly inactivating current 
(Knock, Smirnov & Aaronson 1999; Wang et al. 1998). 
The role of two pore domain K+ channels is unresolved in the myometrium but they 
are thought to be involved in setting resting membrane potential similar to KATP and Kv 
channels. They are inward rectifying channels sensitive to pH, hypoxia and stretch (Brainard, 
Korovkina & England 2007). Isoforms of these channels have been identified in human 
pregnant myometrium (Bai et al. 2005) but not fully elucidated. 
-KATP channels 
ATP-sensitive inward rectifying K+ channels (KATP) maintain basal membrane potential and 
contribute to uterine quiescence throughout pregnancy (Brainard, Korovkina & England 
2007). They are expressed at high levels in non-pregnant myometrium and are down 
regulated in late pregnancy which facilitates myometrial activity necessary for labour 
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(Curley et al. 2002). KATP channels are inhibited by intracellular ATP and stimulated by 
MgADP, coupling cell excitability to metabolic state (Dunne & Petersen 1986a, 1986b). 
Lactate will rise during metabolic stress and during hypoxic conditions and intracellular ATP 
will decrease. This will increase the opening of these channels and lead to reduced uterine 
activity (due to change in membrane potential). 
  
29 
 
1.3 Myometrial force production  
1.3.1 Contraction via MLCK, calcium influx 
To initiate a contraction, calcium needs to enter the cell. This is down its concentration 
gradient: from outside (10-3M) to inside (10-7M) the cell. [Ca2+]i must reach 10
-6M to initiate 
a contraction. Calcium can also be released from the sarcoplasmic reticulum (SR) via 
reversal of SERCA pump or release via IP3 receptors. Calcium can also enter the cell when a 
hormone e.g. oxytocin binds to its receptor (Chapter 1.4.3). 
Calcium inside the cell is bound by calmodulin (Figure 1.4). This complex activates myosin 
light chain kinase (MLCK) by binding to its binding site. This induces a conformational shift 
on inactive MLCK whereby the auto regulatory inhibitory sequence of MLCK moves away 
from the catalytic site activating its enzymatic activity (Olson et al. 1990).  MLCK is a 
serine/threonine kinase that phosphorylates myosin regulatory light chains (MLC20) at 
serine-19 (and threonine-18 at high-agonist concentrations). This initiates actin-myosin 
ATPase on myosin heavy chains generating mechanical energy for contraction (Kamm et al. 
1989). 
1.3.2 Relaxation via MLCP, calcium efflux 
Relaxation of the myometrium is achieved when [Ca2+]i is reduced inside the cell. Removal 
occurs via the plasma membrane or sarcoplasmic reticulum. On the plasma membrane, 
there are two channels which operate to remove Ca2+: the plasma membrane Ca2+ ATPase 
(PMCA) and the Na+/Ca2+ exchanger (NCX).  The NCX extrudes one Ca2+ for three Na+ ions. It 
uses the energy stored in the electrochemical gradient of Na+: Na+ flows down its 
concentration  
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Figure  1.4 Excitation-contraction coupling in the myometrium
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gradient and counter transports Ca2+. The gradient is maintained by the Na+/K+ ATPase. This 
can be reversed if the gradient is reversed i.e. move Ca2+ into the cell. PMCA is electron 
neutral as Ca2+ pumped out is exchanged for two protons (Sanders 2001). PMCAs are 
activated by calmodulin binding, which removes auto-inhibition and increases its affinity for 
Ca2+ (Marin et al. 1999). Both PMCA and NCX make a significant contribution to Ca2+ efflux in 
the myometrium- 70% and 30% respectively (Matthew, Shmygol & Wray 2004).  
L-type Ca2+ channels close when the membrane repolarises. This is caused by K+ channels 
opening by the action potential. Activity of the Na+/K+ ATPase produces a negative charge: 3 
Na+ leave the cell and 2 K+ enter it and this also produces a direct effect on excitability.  
Dephosphorylation of MLC20 occurs by myosin light chain phosphatase (MLCP). This 
phosphatase can also be activated by small G-protein coupled protein kinase cascade 
(Kimura et al. 1996).  
1.3.3 Sarcoplasmic reticulum 
The sarcoplasmic reticulum (SR) is the internal Ca2+ store in all smooth muscle cells. It has a 
Ca2+-ATPase (SERCA) that takes up Ca2+ from the cytoplasm to the lumen of the SR against 
its concentration gradient (at the expense of ATP). Expression of the pump is increased in 
labouring myometrium versus non-labouring indicating increase Ca2+ accumulation takes 
place in labouring myometrium (Tribe, Moriarty & Poston 2000). Within the organelle, 
calsequestrin and calreticulin proteins bind the Ca2+. 
Calcium is released from the SR via Ca2+ channels in the membrane. Agonists, such as 
oxytocin, act to increase [Ca2+]i by generating intracellular second messengers, such as IP3 
which activate these channels. Two types of release channels have so far been identified: 
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inositol 1,4,5-triphosphate (IP3) receptors and ryanodine receptors (RyR). It has been 
demonstrated that RyR are non-functional in the myometrium (Noble et al. 2009). 
Store-operated Ca2+ entry (SOCE) is defined as ‘Ca2+ influx through specific store-operated 
Ca2+ channels as a result of SR Ca2+ depletion’ (Noble et al. 2009). It has recently been 
established that STIM1, a Ca2+ sensor and Orai1, a pore-forming subunit of the SOC channel 
are involved. However store-operated Ca2+ currents have not been reported in the 
myometrium.  
 
1.3.4 Modulation of force 
- Hormonal 
Oxytocin binds to its receptor (OTR) on the plasma membrane. OTR is a G-protein coupled 
receptor (GPCR) coupled to several G proteins including Gαq. This activates phospholipase C 
(PLC). This hydrolyses plasma membrane phosphoinositide biphosphate (PIP2) to produce 
inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 binds to receptors on 
sarcoplasmic reticulum stimulating release of calcium and therefore increase intracellular 
calcium concentration. DAG activates PKC. Both OTR and PKC activate the MAPK cascade 
which leads to prostaglandin production and therefore enhanced contractile activity.  Other 
hormones signal through receptor tyrosine kinases, activating PLCγ generating the same 
intermediates (Taggart & Morgan 2007). 
- Calcium sensitization 
Force can be promoted by Ca2+-sensitising agents that act to increase myosin activity in 
constant [Ca2+]i. These agents act to modulate either MLCP or MLCK. They inhibit MLCP by 
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two mechanisms: RhoKinase phosphorylation of MLCP and inhibition by CPI-17 (Ito et al. 
2004). Activation of Rho, a small G protein, activates Rho-kinase (ROCK) which activates 
myosin by direct phosphorylation or through inhibition of MLCP. It does this by 
phosphorylating the subunit on MLCP. Inhibition of this cascade has only a small effect on 
force (Kupittayanant, Burdyga & Wray 2001). Protein kinase C-potentiated inhibitor protein 
of 17 kDa (CPI-17) when phosphorylated by PKC, inhibits MLCP by binding to its catalytic 
subunit (Somlyo & Somlyo 2000). 
 
1.3.5 Buffering capacity/pH in uterus 
Buffering systems help to maintain pH within physiological range. It is important to maintain 
pH stability as fluctuations in [H+] are dangerous to cells. Rises in [H+] may disrupt cellular 
function and affect enzyme activity. The mean resting value of pHi in pregnant rat 
myometrium is 7.18 (± 0.04). Human myometrial tissue has similar pH values; pHi in non-
pregnant myometrium is 7.06 which rises to 7.14 in pregnant myometrium (Parratt, Taggart 
& Wray 1995a, 1995b).  
There are three important buffering systems in the uterus: bicarbonate, phosphate and 
protein. The function of these systems is to neutralise H+ produced by metabolism to 
prevent alterations in function. Proteins can accept or donate protons due to their structure 
(Acid-base balance  1986). Inorganic phosphate is an effective buffer at physiological pH. 
Monohydrogen phosphate (HPO4
2-) can bind H+ to form dihydrogen phosphate (H2PO4
-). 
H+ + HPO4
2-  H2PO4
- 
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In the bicarbonate buffering system, carbon dioxide (CO2) combines with water (H20) to 
form carbonic acid (H2CO3). This dissociates to bicarbonate (HCO3
-) and protons (H+). When 
[H+] is increased this reaction is shifted; excess H+ will bind to HCO3
- to form H2CO3 then CO2 
and H20. This acts to reduce acidity (Acid-base balance  1986).  
CO2 + H2O  H2CO3  HCO3
- + H+ 
Small transient acidifications (0.04 pH unit) have been seen to follow spontaneous uterine 
contractions (Taggart & Wray 1993b). This has been attributed to a reduction in blood flow 
and therefore a build-up of H+. Alkalinisation occurs within the uterus within last few weeks 
of pregnancy (Parratt, Taggart & Wray 1995a). 
If an acid or base is added to contracting myometrium it results in a change in contractility 
(Parratt, Taggart & Wray 1995b; Pierce et al. 2003). These solutions initially cause a pHo 
change which has been demonstrated to affect the myometrium via pHi changes (Pierce et 
al. 2003). Acidification decreases whilst alkalinisation increases force and [Ca2+]i  both in 
human myometrium (Parratt, Taggart & Wray 1995b) and rat myometrium (Taggart & Wray 
1993a). It has also been demonstrated that acidification acts at the level of cross bridge 
cycling; H+ and Ca2+ compete for binding of the cross bridges (Pierce et al. 2003). 
The myometrial capillary of women in labour has been shown to be high (7.49), consistent 
with alkalinisation of the uterus (Quenby et al. 2004). Women experiencing a dysfunctional 
labour had a decreased blood pH of 7.35. In the same study, it was demonstrated that, in 
vitro, reduce the extracellular pH to 7.3 reduced amplitude and frequency of contractions. 
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1.4 Lactate  
1.4.1 Production 
Lactic acid is a carboxylic acid with the formula C3H603. At physiological pH, it is 
dissociated into a lactate anion and hydrogen ion. Lactic acid is a weak monocarboxylic acid 
with a pKa 3.86. Lactic acid is a chiral molecule and has two optical isomers: L-(+)-lactic acid 
or D-(-)-lactic acid. 
Aerobic respiration is the oxidation of glucose in sufficient oxygen supply (Figure 
1.5). In the first stage- glycolysis- glucose is converted to two 3-carbon molecules of 
pyruvate. 2 molecules of ATP are consumed to initiate the process and 4 molecules of ATP 
and 2 molecules of NADH are produced. Acetyl coenzyme A is formed when each pyruvate 
molecule is oxidised to carbon dioxide and a 2-carbon acetyl group. This binds to coenzyme 
A and enters the mitochondria. Carbon dioxide is released as a waste product. In the citric 
acid cycle the 2-carbon acetyl groups gradually become oxidised. The protons are bound to 
NAD and FAD to form NADH and FADH2 respectively. 2 molecules of ATP are synthesised for 
each glucose molecule (i.e. two pyruvate molecules) entering the mitochondria. In the 
electron transport chain (ETC) the electrons produced in the previous steps are pumped 
across the inner membrane of the mitochondria. They flow through ATP synthase enzyme 
molecules and release energy. 34 ATP molecules are formed from this step. In total 36 
molecules of ATP are synthesised. 
The first step in this respiration process in anaerobic. Oxygen is not used in any of the steps. 
However oxygen needs to be present for citric acid cycle in the mitochondria to continue. 
When there is little/no oxygen, pyruvate oxidation is impaired and is instead reduced by 
lactate dehydrogenase (LDH) to lactate (Figure 1.6). This step involves oxidation of NADH to  
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NAD+. NADH generated in the initial steps of glycolysis which is re-oxidised into NAD+. 
Anaerobic respiration only produces 2 ATP molecules compared to 36 ATP in aerobic 
respiration.  
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Figure  1.5 Aerobic respiration 
Including all four stages of respiration : glycolysis, acetyl coenzyme A formation, citric 
acid cycle and the electron transport chain.
Glycolysis in the cytoplasm
Citric acid cycle in the 
mitochondria
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Figure  1.6 Lactate production in anaerobic respiration
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1.4.2 Use of lactate and breakdown  
Lactate is transported via the blood to the liver where it is involved in the Cori cycle. Lactate 
is oxidised by LDH to pyruvate and glucose is formed in gluconeogenesis. Glucose is released 
back into the blood where it can travel to muscle cells and be utilised in respiration. 
Lactate was originally thought of as a waste product of anaerobic respiration due to its 
presence in hypoxic conditions and was thought to be the primary cause of fatigue. 
However in the last decade, Brooks has changed the role of lactate in metabolism. His group 
determined it is helpful during exercise when oxygen levels are low.  
The idea of cell to cell lactate shuttle was introduced by Brooks in 1985. Skeletal muscle is 
thought to be a major component of this shuttle due to its size and capacity. It is able to 
produce lactate as well as uptake and utilise it. In normal conditions, lactate is released into 
the blood. During short-term high-intensity exercise, lactate is rapidly produced and its 
clearance from muscle is slow. During recovery or long periods of exercise, there is a net 
uptake of lactate from the blood by resting muscles. Muscles that originally released lactate 
may uptake it. Lactate from glycolytic fibres can diffuse to oxidative fibres and lactate can be 
oxidised for respiration. Cardiac muscle is highly oxidative and a high lactate consumer 
(Brooks et al. 2006). As oxygen volume increases lactate becomes preferred fuel for the 
heart. 60% of substrate is utilised (Stanley 1991). In smooth muscle, there is limited 
evidence for this. Smooth muscle is not highly oxidative therefore it is unlikely this 
mechanism is predominant (Steingrimsdottir et al. 1995).  
The blood is the route for lactate to be transported other tissues. Lactate moves via 
monocarboxylate transporters (MCTs) although there is a small amount of diffusion of 
lactate not via transporters. Lactic acid can be up-taken by red blood cells in three ways 
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(Gladden 2004) including MCTs and this is the cells primary pathway. In plasma it is then 
taken up by RBC. Leaves plasma and enters interstitial fluid down concentration gradient.  
 
1.4.3 Monocarboxylate Transporters 
Monocarboxylate transporters (MCTs) are part of SLC 16 family (solute carrier) of proteins 
which has 14 members. Their structures are very similar and they share conserved sequence 
motifs. These transporters consist of 12 transmembrane (TM) helices with an intracellular N 
and C terminus (Figure 1.7). There is a large cytosolic loop between TM 6 and 7 (Halestrap & 
Meredith 2004). 
Only MCTs 1-4 have been shown to transport monocarboxylates, after which they 
were named; molecules such as L-lactate, pyruvate, ketone bodies (acetoacetate, beta 
hydroxybutrate). They are also confirmed to be proton-linked. Other members of the MCT 
family include MCT-8 (SLC16A2) a thyroid hormone transporter and MCT-10 (known as TAT-
1 or SLC16A10) an aromatic amino acid transporter. 
- MCT-1 
This was the first MCT discovered and is found in majority of tissues. The transport of lactate 
and other monocarboxylates is UNIdirectional- it depends on the intracellular/extracellular 
concentration and pH gradient across the plasma membrane. MCT-1 can also exchange 1 
monocarboxylate for another without net H+ transport (Deuticke 1982; Deuticke, Beyer & 
Forst 1982). 
When transporting lactate across the plasma membrane, MCT-1 (and other MCTs) 
first binds H+ (Km 0.2µM) followed by lactate anion (Km 3-5mM) on extracellular matrix 
side. There is a protein conformational change (to the closed formation) which translocates  
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Figure  1.7 Monocarboxylate transporter-1 and lactate
Adapted from Halestrap and Meredith  2004
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the substrate across the membrane.  This exposes lactate and H+ to the opposite side of 
membrane. Lactate is released first then H+. Finally returning to an open conformation 
without bound substance is a rate-limiting step. Transport via MCT can be stimulated by 
drop in pH in cytoplasm (which decreases Km for lactate, increasing affinity for MCT) or 
increased pH on extracellular side 
It has been demonstrated that MCT-1 is up-regulated in response to intense 
exercise/training in skeletal muscle and in the heart in response to hypertrophy (Bickham et 
al. 2006; Bonen 2001). 
- MCT-4 
MCT-4 is widely expressed especially in glycolytic tissue such as white skeletal muscle fibres, 
white blood cells and astrocytes (Halestrap & Meredith 2004). It is therefore important in 
tissues that rely on glycolysis. For example, the adult heart has no MCT-4 present yet in the 
neonate heart, MCT-4 is predominant. This is due to the neonate heart being more 
glycolytic than the adult heart (Hatta et al. 2001). MCT-4 is strongly expressed in placenta 
where it exports lactic acid rapidly from fetal to maternal circulation. It has a lower affinity 
for substrate and inhibitors than MCT-1: the Km value for pyruvate = 150mM. This is to 
avoid pyruvate’s loss from cell, which would prevent removal of NADH formed when 
pyruvate turned into lactate. If this were to occur, glycolysis would cease. The Km for lactate 
is 30mM. 
 MCT-4 is up-regulated in other cells during hypoxia (Perez de Heredia, Wood & 
Trayhurn 2010) and is adapted to efflux over influx of monocarboxylate/H+. 
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- Other MCTs 
There is lower expression of MCT-2 compared to MCT-1 however they are similar as they 
both have higher affinities for pyruvate over lactate. However the tissue distribution of 
these two transporters is different (Garcia et al. 1995; Jackson et al. 1997) and when they 
are expressed in the same tissue, their location within it is different. MCT-2 is strongly 
expressed in the liver (Halestrap & Wilson 2012). The capacity to transport lactate is lower 
in MCT-2 compared to MCT-1 (Broer et al. 1999). 
 MCT-3 is only found in retinal pigment epithelial cells (Halestrap 2013) and choroid plexus 
epithelia (Philp, Yoon & Lombardi 2001). It has a Km value for lactate of 6mM. 
The concentration of lactate is ~3mMol-L in the myometrium. This would indicate that MCT-
1 would be the most important lactate transporter in the uterus, if present. 
- Ancillary proteins 
Basigin (CD147) is a glycoprotein that acts as a chaperone for MCTs (Figure 1.7). It is widely 
expressed, unlike its closely related protein, Embigin, which is not found in many tissues. 
MCT-1 and MCT-4 co localise with Basigin as it is its preferred binding partner. However if 
there is no Basigin, MCT1 will bind to Embigin. In the same way, MCT-2 needs embigin but 
can also bind basigin. MCTs need these proteins to be expressed on the plasma membrane; 
otherwise they would accumulate in the Golgi apparatus. These glycoproteins have a single 
transmembrane domain with a short intracellular C terminus and large glycosylated 
extracellular domain. 
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1.4.4 Lactate in skeletal muscle and heart 
Oxidative fibres use lactate as fuel and there is an increase in lactate during exercise. Lactate 
also transported into cells for gluconeogenesis (generation of glucose from non-
carbohydrate molecules) and lipogenesis (glucose to lipids) – liver and kidney or oxidised in 
heart, skeletal muscle and brain. 
In cardiac muscle, lactate increases cardiac cell excitability by increasing the maximal 
inward sodium current which shifts the voltage dependence of voltage- gated sodium 
channels (Nav) towards hyperpolarised potentials (Guo, Wasserstrom & Rosenthal 1994; 
Tanaka et al. 1994). Lactate has also been shown to reduce chloride conductance, increasing 
excitability of rat skeletal muscle (de Paoli et al. 2010).  
 
1.4.5 Lactate in the uterus and other smooth muscles 
 The myometrium produces lactate in both non-pregnant and pregnant states with 
myometrial contractions shown using 31P NMR (Wray 1990). Lactate production was 
increased in the presence of cyanide, a metabolic inhibitor, which increased lactate efflux. 
Higher amounts of lactate produced in normoxic conditions when compared to other tissues 
due to a higher rate on anaerobic respiration (Shimizu et al. 2000).  
In vascular smooth muscle, it has been shown that lactate can cause vasodilation and 
depressed responsiveness to agonists (Barron & Nair 2003) and it is suggested this is due to 
depressed Ca2+ permeability. Lactate has also been shown to induce arterial relaxation by 
the activation of Ca2+-activated K+ channels (Mori et al. 1998).  
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1.4.6 Lactate and pregnancy and parturition 
Quenby et al recently examined lactate levels in myometrial capillary blood of women 
undergoing caesarean sections. Higher lactate was found in dysfunctionally labouring 
women: 2mmol/L in women contracting normally and this was raised to 3.5mmol/L in 
dysfunctionally labouring women (Quenby et al. 2004). This is also in conjunction with a 
lower blood pH. 
Measurements of lactate in the amniotic fluid of women during parturition and is currently 
being used for dysfunctional labour predictor. Lactate levels in amniotic fluid are higher than 
myometrial capillary blood: 8.9mmol/L spontaneous vaginal delivery and 10.9mmol/L labour 
dystocia (Wiberg-Itzel et al. 2010).  
  
46 
 
1.5 Pregnancy and Labour  
Normal pregnancy lasts around 39-41 weeks. Pre-term pregnancy is classed as delivery of 
the baby before 37 weeks and prolonged pregnancy is usually classed as beyond 41 weeks 3 
days. Some define prolonged pregnancy as more than 42 weeks.  
1.5.1 Onset of labour 
The precise time and sequence of events preceding the onset of labour is unknown. The 
trigger for commencement and factors involved are still to be determined (Figure 1.8). The 
uterus is relaxed throughout pregnancy and becomes more contractile towards late 
pregnancy. A series of genes encoding contraction-associated proteins (CAPs) is suggested 
by Challis and Lye (Challis J 1994). This includes the gap junction protein connexion-43 and 
the oxytocin receptor. Oxytocin levels have been shown to remain the same (Fuchs et al. 
1984). Progesterone is essential in promoting uterine quiescence throughout pregnancy. 
Functional progesterone withdrawal is thought to control onset of parturition; plasma levels 
of progesterone are maintained but the reduction of progesterone receptors lead to 
increased uterine activity (Shmygol et al. 2007). 
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Figure  1.8 Adaptations during pregnancy
Adapted from Garfield and Maner 2007
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1.5.2 Stages of labour 
1. First stage- Onset of contractions and cervical dilation from 0 to 10 cm. 
i. Latent (up to 4cm) 
ii. Active (from 4-10cm) 
Cervix dilates rapidly, minimum 1cm per hour (Friedman 1955) normal 
rate of progress. Frequency and duration of contractions increase to 
become more powerful. 
2. Second stage- expulsive contractions lead to the delivery of baby 
i. Passive 
Presenting part of the baby descends through pelvis till it reaches the 
muscle of the pelvic floor and there is a maternal urge to bear down. 
ii. Active 
Once the mother is pushing or ‘bearing down’, there is further expulsive 
forces leading to the complete delivery of infant. 
3. Third stage- the time from the delivery of the baby to the delivery of placenta and 
membranes. 
-Dysfunctional labour 
- Definition. Dystocia defined as abnormal labour resulting from abnormal power, 
abnormal passage or abnormal passenger. Abnormal power from uterine contractions or 
maternal expulsive forces is the commonest cause of poor progress in labour. Dysfunctional 
labour is not diagnosed until the active phase of labour is achieved. Active labour is defined 
by a cervix opened to 3-4cm with an advanced thinning of the cervix (effacement). 
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The definition of dysfunctional labour is controversial. O’Driscoll in 1969 defined it as 
less than 1cm per hour. However recent NICE guidelines changed this to less than 0.5cm per 
hour ((NICE) 2008). 
The following signs suggest that labour is not progressing as planned/expected: less 
than 3 contractions in 10 minutes lasting less than 40 seconds each, less than 0.5cm change 
in cervical dilation per hour for 2 hours in a row or no change in baby’s descent into birth 
canal after 3 hours of pushing if the cervix is fully dilated (10 cm).  
- Prolonged latent phase    *NO LONGER THAN 8 HRS 
o Cervical dilation up to 4cm 
o Regular painful contractions 
- Prolonged active phase    *NO LONGER THAN 12 HRS 
o Cervical dilation more than 4cm 
o Regular painful contractions 
- Prevalence 
Up to 1/3 of women fail to achieve ‘normal’ contractions to deliver the fetus. Dysfunctional 
labour “is the second leading cause of Caesarean section rates, which in developed 
countries are around double the rate recommended by the World Health Organisation” 
(Pervolaraki 2013). It is associated with significant increased maternal mortality and 
morbidity. These labours account for 20% of all caesarean sections in England and Wales. 
- Treatment 
The administration of oxytocin is currently the only treatment for dysfunctional labour. 
However its use has been questioned as it has no significant effect on reducing caesarean 
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section rates (Bugg et al. 2006). The concentration and length of administration varies 
between hospitals, and high-dose regimes are associated with a reduction in labour 
duration, reduction in CS rates and increase in vaginal deliveries (Mori 2013). However high 
concentrations of oxytocin are not commonly used as it leads to sustained tonic 
contractions and fetal hypoxia (Bugg, Siddiqui & Thornton 2013). If oxytocin is unsuccessful 
in starting/maintain frequent contractions of sufficient power, a caesarean section is 
needed to deliver the baby safely. Additional risks are involved with surgery and with 
dysfunctional labour there is significant increase of morbidity and mortality for both mother 
and baby.  
It has been suggested that increasing intravenous (IV) fluids during labour, to keep women 
adequately hydrated, may reduce the duration of labour as “adequate hydration and… 
supplemental glucose is required to maintain endurance and muscle efﬁciency during the 
process of labour and parturition” (Dawood 2013). It has also been postulated that 
administration of these fluids may reduce CS in women experiencing prolonged labours 
(Garite 2000). When compared to oral intake alone, the administration of IV fluids did 
decrease labour duration, however this did not significantly reduce the number of CS carried 
out (Dawood 2013). 
Dysfunctional labour is an enormous health and economic issue that needs to be addressed. 
Scientific insight is needed into these labours to develop treatments which will eventually 
lead to a cure. Lactate appears to be increased in these labours, indicating it could be 
involved. However, there is no direct evidence of this as yet. My hypothesis is that more 
lactate is being produced in these labour compared to normal labours. This increase causes 
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a drop in pHi which has been show to affect Ca
2+ channels. Ca2+ transients are inhibited and 
therefore myometrial contractility is affected. 
 
  
52 
 
1.6 Aims 
As there are no data that examines the functional effect of lactate on myometrial 
contractility or its mechanism of action, the focus of this work was to investigate the effect 
of lactate on myometrial contractility. The aims of this study were to: 
i) To investigate the effect of lactate on spontaneous and oxytocin-driven contractile 
activity in rat  and human myometrial contractility 
ii) to compare the effects of other weak acids on spontaneous and oxytocin-driven 
contractions on rat myometrium 
iii) to investigate the mechanistic action of lactate, looking at its effect on intracellular 
pH and calcium signalling and how the response to lactate is altered with gestational 
state. 
iv) To investigate the presence of MCT-1 and 4 in the myometrium 
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Chapter 2 
Methods 
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Chapter 2 
General Materials and Methods 
 
This chapter will give a general description of the materials and 
methods used throughout the thesis. More detailed explanations 
and relevant chemicals will be found in the relevant chapters. 
2.1 Animal Tissue 
Use of animal tissue 
 Animal tissue is more readily available than human myometrial tissue and smooth 
muscle from the rat is commonly used as a model for human tissue (Wray 1993, 2001) as it 
behaves in a similar manner to the uterus. Animal tissue also allows different time-points in 
pregnancy to be obtained; similar time-points are unavailable in human tissue. 
Female virgin Wistar rats (Charles River, Kent UK) were time-mated with the male rats 
going in/taken out of the cage being classed as Day 0/1. When pregnant, rats at different 
gestational ages were killed and dissected accordingly (e.g. 11 day gestation at Day 11). 
Term tissue was taken from rats that were within 24 hours of labour (Day 22/23). Labouring 
tissue was taken on Day 23 when the rat had begun to litter and at least one pup had been 
delivered. Non-pregnant uterine tissue was taken from virgin Wistar rats.  
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Collection 
Animals were culled with full compliance with the code of practice for the humane killing of 
animals under schedule 1 of the Animals (Scientific Procedures) Act 1986. Rats were placed 
in a culling chamber and subjected to a rising CO2 concentration. Death was confirmed by 
cervical dislocation. Pups were delivered manually by caesarean section and culled via 
cervical dislocation. The uterus was then removed and placed straight into fresh 
physiological saline solution (PSS solution, composition given below). If tissue was being 
used for protein extraction and western blotting, tissue was collected on ice-cold PSS. The 
tissue was used for contractility experiments and/or frozen on day of collection.  
 
Dissection 
The whole rat uterus was placed on a dissection dish and covered with fresh PSS. A 1cm 
chunk of uterus was cut from the ovarian end of either uterine horn, with the rest of the 
uterus was placed back into PSS and stored at 4oC. The 1cm piece was then cut 
longitudinally and opened out, with the inner endometrium side facing down. Serosal cells 
were carefully cleaned away using cotton buds soaked in PSS. Longitudinal myometrial strips 
of 1mm x 5mm in size were dissected from the uterine portion. If the tissue was to be used 
for protein extraction and western blotting, strips were weighed and flash frozen in liquid 
nitrogen. They were stored at -80 oC until enough samples were collected to commence 
extraction. If myometrial strips were to be used in contractility experiments, aluminium clips 
were attached at each end. 
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2.2 Human tissue 
Although rat smooth muscle is commonly used as a human model, some experimental 
manoeuvres may not yield similar results in both animal and human tissue. For example in 
rodents, progesterone levels decrease to initiate parturition whereas in humans, this isn’t 
the case (Mitchell & Taggart 2009).  This is why human myometrial samples have been used 
in some experiments in this thesis. 
 
Collection and storage 
A full thickness myometrial biopsy measuring 1cm x 1cm was taken at the end of lower 
segment caesarean section, from the upper lip of the uterine incision. Tissue was removed 
after the baby had been delivered and before oxytocin injection, which is administered to 
prevent post-partum haemorrhage. Biopsies of non-pregnant myometrium were taken from 
women undergoing hysterectomies and were removed immediately after the uterus had 
been removed from the patient. Biopsies were taken from the lower half of the anterior 
uterine wall, in the same position as pregnant biopsies. 
All biopsies were placed in Hank’s balanced salt solution and transported to the 
Physiology department. Portions of tissue were taken and fixed in neutral buffered formalin 
(NBF) or flash frozen in liquid nitrogen and stored at -80oC for future experiments. Tissue 
strips were dissected from biopsies and used on the day of collections or the next day after 
overnight storage at 4oc. It has been shown that human myometrial tissue stored at room 
temperature for up to 18 hours did not behave differently to freshly collected tissue (Popat 
& Crankshaw 2001; Senchyna & Crankshaw 1999).  
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Types of biopsies 
All studies relating to the use of human tissue had approval of the local ethics 
committee and written, informed consent from each patient taking part in the study. A 
further application was submitted and accepted for use of tissue in the Myometrial 
Research Tissue Bank (MRTB) at Liverpool Women’s hospital. Patients were consented by 
research midwives at pre-operative clinic or by clinicians in the hospital’s Delivery Suite. 
All pregnant myometrial tissue was obtained from caesarean sections performed at 
term (37-40 weeks). In regards to non-pregnant tissue was obtained from women 
undergoing hysterectomies at Liverpool Women’s hospital. Those that were on medication, 
those that had abnormal smears or were having hysterectomies for endometriosis were 
excluded from this project. 
 
Dissection 
Biopsies were pinned out on a dissection plate in PSS at room temperature. Samples were 
cleaned of blood and endometrium using PSS soaked cotton buds. Blunt dissection, by 
opening scissors in a gap between bundles, was done to expose myometrial bundles. This 
was done to reduce the trauma to tissue. As the majority of fibres run in the same direction 
in pregnant tissue, it was easier to dissect than non-pregnant tissue that has interwoven 
muscle fibres. Small myometrial strips 1 x 5mm in size were removed and treated in the 
same way as animal tissue. 
 
58 
 
2.3 Solutions and chemicals 
Unless stated, all chemicals were obtained from Sigma (Poole, Dorset, UK). 
 
a. Salts – all salt solutions were freshly prepared on a daily basis  
 
i. Physiological saline solution (PSS) 
 
Sodium chloride (NaCl) 154mM 9.00 g/L 
Potassium chloride (KCl) 5.6mM 0.42 g/L 
Magnesium sulphate 
heptahydrate (MgSO4) 
0.12mM 0.29 g/L 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic 
acid buffer (HEPES) 
10.9mM 2.60 g/L 
Glucose 8mM 2.10 g/L 
Calcium chloride (CaCl2) 2.0mM 2ml/L 
Distilled H20 (dH20)  1000mL 
 
The pH of the solution was adjusted to 7.40 using sodium hydroxide (NaOH). 
HEPES is an effective buffer at pH between 6.8 and 8.2. If solutions were needed 
below pH 6.8, 2-(N-morpholino)ethanesulfonic acid (MES) buffer was used. For 
solutions above 8.2, N-cyclohexyl-3-aminopropanesulfonic acid (CAPSO) buffer 
was used. 
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ii.  High potassium PSS  solution (known as High K+) was made by isosmotic 
replacement of NaCl with KCl: 
NaCl    114mM 6.99 g/L 
KCl    40mM  2.98 g/L 
All other ingredients were identical to normal PSS. 
 
iii. Sodium Lactate (and other weak acids) was made by isosmotic replacement of 
NaCl with sodium lactate, or other weak acid: 
NaCl    134mM 7.80 g/L 
Sodium Lactate (Lac)  20mM  2.24 g/L 
 
NaCl    134mM 7.80 g/L 
Sodium Propionate (Prop) 20mM  1.92 g/L 
 
NaCl    134mM 7.80 g/L 
Sodium Butyrate (But) 20mM   2.20 g/L 
 
NaCl    134mM 7.80 g/L 
Sodium Pyruvate (Pyrv) 20mM   2.20 g/L 
All other ingredients were identical to normal PSS. 
Lower concentrations of weak acid solutions were made by diluting in PSS. 
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iv.  High potassium lactate (KCl-Lac) solution: 
NaCl    94mM  5.50 g/L 
KCl    40mM   2.98 g/L 
Lac    20mM  1.92 g/L 
All other ingredients were identical to normal PSS. 
 
v. Ammonium chloride (NH4Cl) solution: 
NaCl    149mM 8.71 g/L 
NH4Cl    5mM  0.27 g/L 
  All other ingredients were identical to normal PSS. 
 
vi. Ammonium chloride lactate (NH4Cl-Lac) solution: 
NaCl    144mM 8.42 g/L 
NH4Cl    5mM  0.27 g/L 
Lac    5mM  0.56 g/L 
 All other ingredients were identical to normal PSS. 
 
 
b. Oxytocin  
Oxytocin was dissolved in dH20 at a concentration of 10mM. Desired concentrations 
were obtained by diluting the stock solution with PSS. For animal tissue, it was used 
at [0.1nM]. For human, [0.5nM] oxytocin was used. 
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2.4 Tension measurements 
Calibration of force 
Force was calibrated in Newtons (N) and done so by comparing force traces to those 
obtained from a known amount of force. This was achieved by suspending known weights 
from the force transducer and measuring the deflection. 0.1g weight is equal to 1mN (N is 
kg.ms-2). 
 
Control contractions 
Tissue was attached to the fixed hook and force transducer using the aluminium clips in 
1ml perfusion bath (Figure 2.1). The tissue strips were then stretched by 2mN. Strips were 
continually superfused with PSS solution. The force transducer was attached to a digidata 
acquisition package and Axoscope software. In animal tissue, if contractions appeared 
within 20 minutes, KCl was applied to gain the tissue’s maximal activity and used in future 
analysis. A further 5 minutes of control contractions (of equal amplitude and duration) were 
needed before an experiment would begin. If no contractions appeared, KCl would be 
applied to test viability and check amount of stretch applied. 
Human tissue was attached in a similar manner and stretched to 2mN. If contractions 
appeared within 3 hours, at least 20 minutes or 4 contractions of equal amplitude were 
needed before an experiment would start. If no contractions were seen, KCl was used to 
test viability. If a good KCl response, oxytocin was applied. If no/ little KCl, strip was 
discarded. 
Tissues were able to produce stable, regular contractions for many hours (Figure 2.1). 
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Figure 2.1 Measurement of contractile activity
Myometrial strips , measuring  1x5mm in size,  are dissected from either rat uterus or 
human myometrial biopsies. Using aluminium clips, tissue was attached to a fixed hook 
and force transducer. This was superfused with physiological saline solution at 37oC, pH 
7.4.  Contractility was then measured.
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0
Rat Myometrium
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Figure 2.2 Control contractility traces
Two hours of contractions from small myometrial strips from: 
A. Term pregnant rat
B. Term pregnant human showing no decline in force.
A
B
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Analysis of contractility 
Four main parameters that were analysed from all contractility experiments using Origin 
Pro 8.6 software (Figure 2.2).  
 
Force amplitude 
Force amplitude (mN) is calculated by subtracting the baseline from the peak of 
contraction. An average of 5 minutes of contractions (in rat) or 20 minutes or 4 
contractions in (human tissue) were needed before drug/treatment could be added. This 
was termed ‘control’. The control period was compared to an average of 5 minutes (rat) 
or 20 minutes or 4 contractions (human) in the presence of a drug or treatment. The 
difference in time measured between species is to account for slower rate of 
contractions seen in human myometrium. If there were no contractions, it was recorded 
as ‘0’. 
 
Duration 
Duration is the measured time (minutes) of contraction at half maximal amplitude 
(t50). The average time of all contractions in control or treatment period were used in 
statistical analysis. Where contractions ceased, they were removed from analysis. 
 
Frequency 
The interval between the start of one contraction and the start of the next was 
measured for all contractions in the control or treatment period.  The time in the period 
being analysed (e.g. 5 minute control) was divided by the average time per contraction 
to give an accurate number of contractions in the set time. 
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Area under the curve (A.U.C.) 
The AUC is also known as mean force integral. This gives a good indication of the 
overall effect of all the other parameters together. A period of 5 minutes (rat) or 20 
minutes (human) was selected and area under the curve measured using Origin Pro 8.6 
software. In some cases, the last 2 minutes (rat) or 5 minutes (human) on a given control 
or treatment period were analysed to give an accurate measure of the effect of the 
treatment. If there were no contractions, it was recorded as ‘0’. 
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Force amplitude (mN)
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Rat             5mins
Human      20mins
Rat             5mins
Human      20mins
Rat             last 2mins
Human      last 5mins
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Force
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Figure 2.3 Measured parameters of contractility
A. Amplitude is measured from baseline to peak of contraction (mN).
B. Duration is measure at half maximal amplitude (minutes).C 
C. Frequency is the number of contractions in a given time period. For rat data this is 5 
minutes, for human, 20 minutes.
D. (i) Area under the curve (AUC) is measured using Origin Pro 8.6 software in a given time 
period. In some instances the last 2 minutes (rat) or last 5 minutes (human) were analysed 
(ii).
A B
C
D(i) D(ii)
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2.5 Fluorescent indicators 
The concentration of intracellular ions is important in the regulation of cell function. 
Changes in the concentration of ions in the cytosol affects things like membrane potential, 
osmoregulation and can act as second messengers. Intracellular calcium is the main ion 
responsible for the contraction of smooth muscle. However, variations in pHi are also 
responsible for enzymatic function, protein structure and ionic species. Fluorescent probes 
are useful tools for investigating intracellular ions. Reasons for this include their ability to be 
incorporated into tissue without damaging the plasma membrane, they can be used in 
single cells or multicellular preparations and they allow the free concentration of ions or 
their activity to be measured (Tsien 1989). 
Fluorescence allows the detection of particular ions in tissue by the use of fluorescent 
probes. These are designed to respond to a stimulus. The fluorescence process occurs in 
three stages: 
1. Excitation 
2. Excited-state 
3. Emission  
In stage 1, a photon of energy is supplied by an external source (e.g. xenon lamp) and 
absorbed by the fluorophore. This creates an excited electronic singlet state. The excited 
state exists for a finite time (stage 2). The fluorophore undergoes conformational changes 
and its energy is partially dissipated. In stage 3, a photon of energy is emitted returning the 
fluorophore back to its ground state. Because of the energy dissipation during its excited 
state, the energy of the photon is lower (and therefore a longer wavelength). The difference 
in energy or wavelength is called the Stokes Shift (Invitrogen Mol Probes). 
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 Ratiometric indicators are used within this thesis and are based on the use of a ratio 
between two fluorescent intensities. Fluorophores can be dual excitation, where excitation 
alternates between two different wavelengths. The fluorescence emission is captured at a 
single wavelength. Fura-2 is an example of a dual excitation fluorescent indicator. It is 
excited at 340nm and 380nm and emission is measured at ~510nm (ShmigolJPhysiol2001). 
Dual emission indicators are excited at one wavelength, which is true for Indo-1, which is 
excited at 350nm and emission fluorescence is measured at 400nm and 500nm 
simultaneously. The ratio of the emission fluorescence is obtained by dividing the 400 
intensity by the 500 intensity. Ratiometric indicators allow for the correction of artefacts 
due to photobleaching, focus changes and variations in laser intensity and uneven dye 
loading or dye retention. 
 
Measurement of intracellular calcium and pH 
 Indo-1 AM was developed by Roger Tsien and collaborators and allows the 
measurement of intracellular calcium (Grynkiewicz, Poenie & Tsien 1985). Its structure is 
based on 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), an EGTA 
homologue with a high selectivity for calcium and is more pH insensitive (Harrison & Bers 
1987). This is due to the presence of carboxylic acid groups which are able to bind calcium 
ions (Figure 2.3). When excited at 350nm, the emission shifts from ~500nm without calcium 
to 400nm with calcium (Figure2.3). 
1,5-(and 6)-carboxyseminaphtorhodafluor-1-acetoxymethy ester (Carboxy-SNARF) is a 
ratiometric pH-sensitive fluoroprobe (Figure 2.4).It is excited at 540nm and the emission 
collected at 590nm and 640nm wavelengths, where it shifts toward 590nm when acidic 
(Figure 2.5). The value is dependent on dye concentration, path length and excitation 
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intensity but this dual-emission dye is better than the dye previously used- BCECF, a dual 
excitation fluoroprobe, which is excited sequentially. The signal-to-noise ratio worse as one 
wavelength is weaker and more pH-insensitive than the other (Buckler & Vaughan-Jones 
1990) Carboxy-SNARF is used as it pKa value is close to physiological pH of cell (Bond & 
Varley 2005).  
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Figure 2.4 Indo-1 AM structure
The ester form of Indo-1 is able  to pass freely across the cell membrane. Once inside the 
cell, esterases cleave the ester group and it is unable to  freely leave the cell. Here is it 
able to bind calcium.(Adapted from dojindo.com)
cell membrane
esterase
Indo 1- Ca2+ complex
Indo 1
Polar, Ca2+ sensitive
Indo 1 AM
Non-polar, Ca2+ insensitive
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Figure 2.5 Carboxy SNARF-1 AM structure
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Figure 2.6 Fluorescence emission spectrum for Indo-1 AM and Carboxy SNARF-1 AM
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The acetoxymethyl ester (AM) ester form of the dye is used to allow the dye to 
permeate the cell membrane. This is because this form of the indicator is uncharged and 
hydrophobic and can therefore cross the lipid membranes (Bootman et al. 2013). Once 
inside the cell, endogenous cytosolic esterases cleave ester groups, charging the molecule. 
The carboxyl groups in the indicator are also essential for the indicator to sense Ca2+ or H+ so 
the AM groups need to be removed. This form of the indicator leaks out of the cell more 
slowly (Invitrogen). 
Loading of fluorescent indicators into tissue can be increased by using Pluronic F-127, a 
dispersing agent. This is a mild non-ionic detergent that facilitates cell loading of water-
insoluble dyes (Bootman et al. 2013). The indicator is reconstituted in an anhydrous 
dimethylsulfoxide (DMSO) to form a DMSO-Pluronic mix. Gentle warming is needed to assist 
getting the detergent to dissolve into DMSO. 
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1. Calibration of Carboxy SNARF-1 for pHi measurements 
Nigericin 
Nigericin is H+ K+ antiporter. It is used to ‘clamp’ pHi at the external PH (pHo) by 
equilibrating the potassium concentration. When internal and external potassium 
concentrations are equal, protons can move freely across the plasma membrane so 
therefore pHi should equal pHo (Thomas et al. 1979). 
 
Nigericin calibration solution (dissolved in EtOH): 
KCl   140mM 
MgCl2  117mM 
Nigericin  10µM 
20mM buffer was added to the calibrations solution as follows and adjusted to 
desire pH at 37oC with NaOH: 
pH 5.5   MES 
pH 6.5, 7.0, 7.5, 8.0 HEPES 
pH 9.0   CAPSO 
 
Mock intracellular solution 
Using a mock intracellular solution: 
NaCl  10mM 
KCl   146mM 
MgSO4  4mM 
ATP  4.5mM 
HEPES  11mM 
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1µM free acid Carboxy SNARF-1was added and pH adjusted to known values (pH 5.0, 
6.5, 7.0, 7.5, 8.0, 9.0). Fluorescence was measured using these solutions and a 
calibration graph using the ratio vs pH. 
 
From this, the Rmin, Rmax and PkA can be calculated and used in the equation below to 
calculate pH.  
pH = pKa + log [R-Rmin/(Rmax-R)] 
 
Nigericin has been shown to be unreliable in tissues/multicellular smooth muscle 
preparations as the ionophore is slow to diffuse (Taggart & Wray 1993a) and can persist 
in tubing and tissue baths (Buckler & Vaughan-Jones 1990). There is good agreement 
between the two calibration methods (Austin & Wray 1993). 
 
 
 
 
 
 
76 
 
Advantages and disadvantages of using fluorescent indicators 
Photobleaching  
Photobleaching is the destruction of the fluorophore under high-intensity illumination 
conditions. It can be prevented by only subjecting the loaded tissue to illumination for 
the shortest time possible. The use of neutral density filters placed in front of the 
excitation light is also encouraged to reduce the intensity of light exciting the tissue 
(Tsien 1989). Although the de-esterified indicator is essentially membrane impermeant, 
some anion transporters in the plasma membrane can cause clearance of fluorescent 
indicators. This loss is temperature sensitive (Kao 1994; Thomas et al. 2000). In the 
experiments conducted in this thesis, tissue loaded with fluorescent indicators were not 
in focus (i.e. away from direct light excitation) until an experiment is ready to begin. 
 
Autofluorescence 
Autofluorescence is the natural emission of light by structures that have absorbed light, 
without the presence of fluorphores. The most common autofluorescencing molecules 
include NADPH, riboflavin and FAD (Takahashi et al. 1999). The extracellular matrix can 
also contribute to this phenomenon. The contribution of autofluorescence to the 
overall fluorescence signal can be measured by quenching with manganese (Hesketh et 
al. 1983). The measured emission is subtracted from total signal. 
 
Subcellular compartmentalisation of fluorophores 
 Fluorescent indicators can become compartmentalised by organelles within the cell 
such as the sarcoplasmic reticulum and mitochondria (Thomas et al. 2000). Indo-1 is 
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less prone to compartmentalisation than Fura-2, although it is also less resistant to 
photobleaching (Scheenen et al. 1996). 
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2.6 Force and calcium or pH measurements 
Both fluorescent indicators used in these experiments were prepared using dissolved 
DMSO/Pluronic F-127 mix. There is no significant effect on contractility at the 
concentration used in these experiments (Taggart et al. 1997). 
 
Loading Indo-1 AM 
To monitor changes in intracellular calcium signalling, 50µg of Indo-1 AM was 
dissolved in 50µL of solution of 200µL DMSO and 0.05g Pluronic acid. This mix was 
added to 4mL PSS and vortexed. This creates a concentration of 12.5µM Indo-1 AM. The 
Indo-1 AM-PSS mix was split between two 5mL vials and dissected myometrial strips 
were added to each- no more than 6 strips per vial. Vials were placed on a rotator plate 
for 3 hours at room temperature. Loaded strips were washed with fresh PSS before use 
in experiments. 
 
Loading Carboxy-SNARF 
The ratiometric pH indicator Carboxy SNARF-1 AM was used to monitor changes in 
intracellular pH. 50µg of the indicator was dissolved in 50µL of solution of 200µL DMSO 
and 0.05g Pluronic acid. This was added to 4mL PSS and vortexed. This creates a 
concentration of 12.5µM. The Indo-1 AM-PSS mix was split between two 5mL vials and 
dissected myometrial strips were added to each- no more than 6 strips per vial. Vials 
were placed on a rotator plate for 2 hours at room temperature. Loaded strips were 
washed with fresh PSS before use in experiments. 
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Simultaneous measurement of force and calcium or pH  
Tissue in bath attached to transducer resting tension 2mN. Once contracting, 
focused on tissue and excited by U.V. illumination is provided by a xenon lamp (Figure 
2.6). A heat filter, a neutral density filter are placed in the light path to prevent excess 
heat and reduce light intensity reaching the tissue. The appropriate excitation 
wavelength is selected by way of interference filter. For calcium measurements using 
Indo-1 AM, the excitation wavelength is 345nm; for pH measurements using Carboxy-
SNARF, the excitation wavelength is 450nm. An electromagnetic shutter blocks the path 
of light to reduce illumination time of the tissue and prevent photobleaching. This is 
used until a control period of contractions is established. The excitation light is reflected 
and directed upwards by a dichroic mirror (DM1) and focused onto the tissue by the 
microscope objective. The light emitted by the fluorescent indicator is passed back 
through the objective and transmitted by the dichroic mirror (DM1) reflected by the 
sliding mirror. The light hits a second dichroic mirror (DM2) at 610nm, mounted at a 45o 
which directs longer wavelength emitted light (>610nm) to form an image on the video 
camera which relays the image to the TV monitor. The shorter wavelength light 
(<610nm) is directed towards the photomultipliers (PMTs). The shorter wavelength light 
is split by another dichroic mirror (DM3) and passes to either PMTs. In front of each PMT 
is an appropriate emission filter to select the correct wavelength of light. For calcium 
measurements, this is 400nm and 500nm and for pH measurements this is 590nm and 
640nm.  
 The signals detected by the PMTs and force transducer provide a recording on the 
Axoscope software (Figure 2.7). The rise and fall of intracellular calcium or pH are 
measured from the ratio of the two emission signals.  
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Figure 2.7 Schematic diagram of the inverted microscope used to make simultaneous 
force/calcium measurements.
U.V. illumination is provided by a xenon lamp (1). A heat filter (2) neutral density filter (3) are 
placed in the light path to prevent excess heat and reduce light intensity reaching the 
specimen. The appropriate excitation wavelength is selected by way of interference filter (4). 
An electromagnetic shutter (5) block the path of light to reduce illumination time of the tissue 
and prevent photobleaching. The excitation light is reflected and directed upwards by a 
dichroic mirror (DM1) and focused onto the tissue by the microscope objective (6). The light 
emitted by the fluorescent indicator is passed back through the objective and transmitted by 
the dichroic mirror (DM1) reflected by the sliding mirror. The light hits a second dichroic 
mirror (DM2) at 610nm, mounted at a 45o which directs longer wavelength emitted light 
(>610nm) to form an image on the video camera which relays the image to the TV monitor. 
The shorter wavelength light (<610nm) is directed towards the photomultipliers (PMTs, 9). 
The shorter wavelength light is split by another dichroic mirror (DM3) and passes to either 
PMTs. In front of each PMT is an appropriate emission filter to select the correct wavelength 
of light. Microscope lamp (10)
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Figure 2.8 Simultaneous force and calcium trace
A. A typical trace showing separated F400 and F500 channel, ratio of the two and force.
B. One contraction showing rise in intracellular calcium before force begins to increase.
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2.7 Western blotting 
Protein extraction 
 Radio-Immunoprecipitation assay (RIPA) buffer was used to allow efficient cell lysis 
and protein solubilisation. It also avoids protein degradation as it contains phosphatase and 
protease inhibitors, and does not interfere with biological activity. 3mL RIPA buffer per 1g 
tissue was used. 
PBS tablets   2 tablets 
IGEPAL    1% 
Sodium deoxycholate  0.5% 
SDS    0.1% 
Small chunks of tissue from time-mated animals or human myometrial biopsies, that had 
been previously snap frozen in liquid nitrogen and stored at -80oC, were homogenised using 
a pestle and mortar and liquid nitrogen until it was a fine powder. RIPA buffer was added 
and the sample re-ground. Samples were centrifuged at 10000 RCF (g) at 4oC for 10 minutes. 
The pellet was discarded and the supernatant frozen before quantification using in a protein 
assay. 
 
Protein quantification 
Bio-Rad detergent compatible (DC) protein assay was used to quantify the amount of 
protein present in the samples. This is because the RIPA buffer used to extract the proteins 
contains SDS, a detergent. The colourmetric assay is based on the Lowry method, which 
uses the reaction of cupric ions with peptide bonds under alkaline conditions, using a Folin-
Ciocalteu reagent. This is a modified-Lowry based assay with the following improvements: 
90% of the maximum reaction colour occurs within 15mins and colour changes no more 
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than 5% in 1hour. The same RIPA buffer that was used for the protein extractions was used 
in the assaying of the samples. 2mg/ml protein standard (0.01g bovine serum albumin (BS) 
in 5mL RIPA buffer) was made, from which a set of protein standards were also made (0, 
0.1, 0.25, 0.3, 0.5 and 1mg/mL). 20µl reagent S was added to each mL of reagent A. This was 
added to the protein standards and the proteins of interest. All solutions were vortexed and 
left to develop for 15 minutes. The solutions were transferred to cuvettes and the 
absorbance of each sample recorded at 750nm. From this data a standard curve was plotted 
and the unknown protein quantifications could be determined.  
 
Preparation of protein samples 
25µg of protein was added to 3x Laemmli buffer (0.125M Tris-HCl pH6.8, 4% SDS, 20% 
glycerol, 0.004% bromophenol blue, 10% β-mercaptoethanol). These samples were boiled at 
100oC for 3 minutes, vortexed, spun in a mini centrifuge and placed on ice before loading. 
 
SDS_PAGE and Immunoblotting 
 Spacer plates were cleaned with dH20 and 70% EtOH and assembled into casting kit 
ready for gel loading. 
As the proteins of interest in this project were between 17-65 kDA, a 12% resolving gel 
was used (30% acrylamide:bis-acrylamide, 1.5M Tris HCl, pH 8.8, 0.4% SDS, 10% APS, 
TEMED). Gel was poured and overlaid with propylalcohol. This was left for 30 minutes to 
polymerise. The alcohol was then washed off with dh20. 4% stacking gel is added above the 
resolving gel (30% acrylamide:bis-acrylamide, 0.5M Tris HCL, pH 6.8, 0.4% SDS, 10% APS, 
TEMED). Combs were inserted into the stacking gel before polymerisation to create wells for 
protein loading. 
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 20µl prepared protein samples were loaded alongside 5µL protein ladder (SeeBlue® 
Plus2 Pre-stained standard, Invitrogen) which is used during at a later stage to show 
efficient transfer and allow recognition of the protein of interest. Gels were run at 150V for 
2 hours, surrounded by running buffer on ice. Gels were removed, moved to transfer 
cassettes and assembled with nitrocellulose membrane (Whatman Protran). Transfer buffer 
containing 10% methanol was poured in the tank covering the cassettes. Gels were 
transferred at 40v for 1 hour. Membranes were blocked for 1 hour at room temperature in 
5% BSA (in TBS- 0.1% Tween). Membranes were then placed in primary antibodies (Table 
2.1) overnight at 4oc on a rocker. The next day, membranes were washed with TBS- 0.1% 
Tween for 40 minutes. A secondary antibody was added for 1hr at room temperature. A 
further 1 x 15min and 4 x 5min of TBS-0.1% Tween washes. Membranes were incubated in 
chemiluminescent ECL reagent for Horseradish peroxidase (HRP) enzyme for 5 minutes 
(SuperSignal West Pico Chemiluminescent Substrate, Thermo Fisher Scientific). Membranes 
were developed Kodak processing chemicals developer and fixer in a dark room onto film 
(CL-Xposure Film, Thermo Fisher Scientific). 
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PRIMARY 
Antibody Species Mono/Poly? Concentration Diluent Code 
MCT1 Rabbit Polyclonal 1:500 5% BSA Ab85021 
SLC16A3 Rabbit Polyclonal 1:500 5% BSA Ab74109 
β-actin Mouse Monoclonal 1:4000 5% BSA Ab8224 
 
SECONDARY 
Antibody Species Mono/Poly? Concentration Diluent Code 
Anti-rabbit Donkey Polyclonal 1:10,000 5% BSA Ab16284 
Anti-mouse Goat Polyclonal 1:80,000 5% BSA  
 
 
 
 
 
Table 2.1 Antibodies used in western blotting experiments 
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Analysis 
Experiments were analysed using ImageJ. All blots were scanned at 200dpi and saved as in 
the TIFF format. Files were opened in ImageJ and the background subtracted. Multiple large 
rectangular boxes were drawn around the bands. These were long enough to incorporate 
free space above and below the bands to assess background. All boxes were the same size. 
Once all lanes were selected, signal intensities were plotted. These are visualised as peaks 
and troughs. Using the line drawing tool, the areas of each peak (which corresponds to each 
band) were enclosed. Each enclosed area was selected by the ‘wand’ tool to display the area 
under the curve (AUC) for each band. These were exported into Excel for further 
calculations.  
2.8 Statistics 
Graphs and tables were constructed using Origin Pro 8.6, Microsoft Excel 2010 and 
GraphPad Prism 5. Stastistical analysis of data was performed in SPSS Statistics 20. 
If data was normally distributed, the standard deviation and standard error of the mean 
were calculated. Student’s t-test and One-way ANOVA were used as detailed in the relevant 
chapters. If the data was not normally distributed, Wilcoxon Signed-Ranks test, Mann-
Whitney U test and Kruskal-Wallis test were used in the relevant chapters. 
 
For all tests significance was taken as a p value less than 0.05 (p<0.05*) 
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Chapter 3 
The effect of lactate and other weak 
acids on rat myometrial contractility 
and their mechanism of action 
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Chapter 3 
The effect of lactate and other weak acids on rat 
myometrial contractility and their mechanism of action 
3.1 Abstract 
Lactate is produced during anaerobic respiration in all cells during hypoxic conditions 
but has also been shown to be produced during normoxic conditions in the uterus. 
Lactate has been previously shown to increase in the myometrium during dysfunctional 
labour but currently no work has been done to investigate the effect of lactate on the 
myometrial contractility. Myometrial strips from time-mated Wistar rats at various 
gestational time points were dissected and contractility measured. 1mM -20mM sodium 
lactate (and other weak acids: butyrate, propionate and pyruvate) were added to 
spontaneously contracting and oxytocin-driven (0.1nM) tissue strips. In some cases, 
tissue was loaded with Indo-1 AM or Carboxy-SNARF AM to simultaneously measure 
force and intracellular calcium or pHi respectively. 40mM KCl solution was used to look 
at the effect of lactate beyond membrane excitability. Lactate significantly decreased 
spontaneous contractility (n=7-8). A dose dependent decrease in all contractile 
parameters was seen, which was significant at concentrations of 5mM and above 
(relative to control 100%). Other weak acids also significantly reduced contractions in a 
dose dependent manner. There was no significant difference between weak acid 
responses. The effects of lactate were significantly reduced in the presence of oxytocin 
(n=3-6). Lactate decreased intracellular pH and reduced Ca2+ transients. The effect of 
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5mM lactate was more potent at late pregnant myometrium but had little effect on 
early pregnant and labouring tissue (n=4-8). Lactate in the physiological range potently 
decreases spontaneous contractility in rat myometrium. Lactate also decreases oxytocin-
stimulated contractions but its sensitivity is decreased. Other weak acids produce similar 
effects to lactate suggesting its mechanism of action is not via metabolism. Lactate 
inhibited Ca2+ transients, which could be due to a fall of intracellular pH and I suggest 
this is the mechanism whereby lactate and similar weak acids reduce myometrial 
contractions. 
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3.2 Introduction 
Lactic acid is produced by glycolysis in all cells and is dissociated into lactate and a hydrogen 
ion at physiological pH (Philp, Macdonald & Watt 2005). During glycolysis, glucose is split 
into two molecules of pyruvate, yielding two ATP molecules and two molecules of NADH. 
Pyruvic acid progresses through glycolysis and the citric acid cycle (Kreb’s cycle) in the 
mitochondria, if there is ample oxygen. In hypoxic conditions, pyruvic acid is reduced by 
lactate dehydrogenase to lactic acid, which becomes dissociated to lactate and H+. It has 
been shown that the uterus is highly glycolytic even under normoxic conditions 
(Steingrimsdottir et al. 1995; Wray 1990). Lactate is transported out of the cell and 
intracellular pH (pHi) maintained within normal limits and this is mediated by a family of 
proton-linked monocarboxylate transporters (MCTs) (Bonen et al. 2000a; Bonen et al. 
2000b). Lactate and H+ are co-transported down their concentration gradients.   
Our group have previously shown that there is increased lactate in myometrial capillary 
blood from women suffering dysfunctional labour and that this blood is of a reduced pH 
(Quenby et al. 2004). Recent work by others has also reported an increase in lactate in the 
amniotic fluid of women suffering dysfunctional labour (Akerud, Ronquist & Wiberg-Itzel 
2009; Wiberg-Itzel et al. 2008).  Thus increased lactate may be a significant cause of 
dysfunctional labour.  
Intracellular and extracellular pH plays a vital role in all tissues and must be tightly regulated 
within a certain range. In the myometrium, both intracellular and extracellular pH changes 
occur during labour due to vascular occlusion at the peak of uterine contraction (Wray et al. 
1992) and it has already been shown that intracellular acidification can affect contractility of 
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the uterus (Shmigol et al. 1995). Intracellular acidification has been demonstrated to inhibit 
L-type Ca2+ channels and reduce inward Ca2+current (Taggart & Wray 1993b) and cause 
membrane hyperpolarisation thus causing a decrease in force of contraction.  
There are no data that examines the functional effect of lactate on myometrial contractility 
or its mechanism of action. In vascular smooth muscle, it has been shown that lactate can 
cause vasodilation and depressed responsiveness to agonists (Barron & Nair 2003) and it is 
suggested this is due to depressed Ca2+ permeability. Lactate has also been shown to induce 
arterial relaxation by the activation of Ca2+-activated K+ channels (Mori et al. 1998). 
However in cardiac muscle, Lactate increases cardiac cell excitability by increasing the 
maximal inward sodium current which shifts the voltage dependence of voltage- gated 
sodium channels (Nav) towards hyperpolarised potentials (Guo, Wasserstrom & Rosenthal 
1994; Tanaka et al. 1994). Lactate has also been shown to reduce chloride conductance, 
increasing excitability of rat skeletal muscle (de Paoli et al. 2010). Although in smooth 
muscles, it is unclear if the myometrium behaves in a similar way. 
I hypothesise that an increased amount of lactate (and H+) in the myometrium will alter 
contractility and may be a cause of dysfunctional labour. The aims of the study were: 
v) To investigate the effect of lactate on spontaneous contractile activity in rat  
myometrial contractility 
vi) to compare the effect of lactate under oxytocin-driven contractions 
vii) to compare the effects of other weak acids on spontaneous and oxytocin-driven 
contractions 
viii) to investigate the mechanistic action of lactate, on intracellular pH and calcium 
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signalling  
ix) to investigate how the response to lactate is altered with gestational state. 
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3.3 Methods 
3.3.1 Tissue 
Pregnant Wistar rats at term (within 24hours of expected labour) were humanely killed 
using CO2 anaesthesia and cervical dislocation. The uterus was removed, cleaned and 
longitudinal myometrial strips (5mm X 1mm) dissected. Individual strips were mounted 
between a fixed support and force transducer using aluminium clips in a 1ml bath and were 
continuously superfused with PSS (pH 7.40) at a rate of 2mL/min and maintained at 37oC. 
For measurement of intracellular pH or calcium, myometrial strips were loaded with 
fluorescent indicator Carboxy-SNARF AM or Indo 1-AM respectively (12.5µM, 3 hours at 
room temperature.) After loading, the strips were washed for 30mins in physiological saline 
solution (PSS) and mounted.  
3.3.2 Force and calcium/pHi measurements 
Carboxy-SNARF loaded strips were excited at 530nm using a Xenon lamp and emitted light 
was detected by photomultipliers at 590 and 650nm. For Indo-1 AM loaded tissue, the 
wavelengths were 350nm (excitation) 400 and 500nm (emission). Both were digitally 
recorded at a sampling rate of 100 Hz and the ratio of these two signals was used. The pHi 
recordings were calibrated as described in Chapter 2.   A 40mM high potassium (KCl) 
solution was used to test tissue viability and measure maximal force contraction. Contractile 
activity in rat myometrial strips was observed for ~30mins after the application of 40mM KCl 
for 1 minute until steady contractions appeared. Once stable contractions were established, 
contractility was manipulated with elevating sodium lactate solutions (1-20mM, pH 7.40) 
and other weak acids: sodium butyrate, sodium propionate and sodium pyruvate. 
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3.3.3 Solutions 
Buffered physiological saline solution (PSS) composed of (mM): NaCl 154, KCL 5.6, MgSO4 
1.2, CaCl2 2, Glucose 8 and HEPES 10.2. 40mM KCL was made by isoosmotic replacement of 
sodium chloride. Oxytocin was added to PSS at a final concentration of 0.1nM (rat) 0.5nM 
(human.) All chemicals were obtained from Sigma, Poole, Dorset, unless otherwise stated. 
Carboxy-SNARF and Indo 1-AM were obtained from Molecular probes.  
3.3.4 Analysis and statistics 
Data was analysed using Origin 8.6 (Microcal) and n is the number of myometrial tissue 
strips from different animals. Amplitude, duration and area under the curve (a.u.c.) of each 
contraction was measured and the average in the last two minutes of solution application 
was used. Frequency was measured as the number of contractions in the total lactate 
application. Data is presented as % of control period (taken as 100%). The data was found to 
be normally-distributed and statistical differences were tested using parametric statistical 
tests in SPSS Statistics 20. Significance was taken as P<0.05. 
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3.4 Results 
3.4.1 Effect of lactate on spontaneous contractility 
5mM lactate was applied for 10 minutes to spontaneously contracting rat myometrium 
(n=3) (Figure 3.1). As shown in Figure 3.1, the response to lactate plateaued after 5 minutes. 
Therefore, for future experiments, an application time of 5 minutes was chosen. Increasing 
concentrations of sodium lactate (1-20mM) were applied extracellularly to myometrial 
strips for 5 minutes and the effects on contractility determined (n=7-8) (Figure 3.2). Lactate 
caused a reduction and abolition of contractile activity and this response was dose 
dependent (Figure 3.2 Ai-v).  Once lactate was removed and the myometrium returned to 
PSS, contractions resumed and returned to control values. There was a significant decrease 
in contractile parameters- amplitude, frequency and A.U.C. of contractions when compared 
to the preceding control period (Paired students t-test, p<0.05) (Table 3.1). The amplitude 
and frequency of contractions were significantly reduced at 5mM lactate and higher. A.U.C 
was significantly decreased at concentrations ≥ 3mM. There was a significant difference 
between lactate concentrations in these three parameters (One-way ANOVA with 
Bonferroni Post-hoc test) (Figure 3.3 Ai, ii and iv). It should be noted that 5mM lactate 
completely abolished contractions in 4 out of total 8 tissue strips tested (Figure 3.4 Ai). 
 A.U.C. values were used to plot a dose response curve as percentage reduction of a.u.c. 
compared to control period (Figure 3.3 Biv). From this dose-response curve the EC50 for 
lactate (the concentration at which contractile activity is reduced by 50%) was calculated. 
The EC50 on spontaneously contracting rat tissue was 3.9 ± 0.3 mM. 
  
96 
 
 
Figure 3.1 Effect of 10 minute application of 5mM lactate on rat myometrium
A: Isometric recording of the application of 5mM lactate to spontaneously contracting rat 
myometrium for 10 minutes (i) and a paired tissue strip exposed to PSS for the same 
length of time (ii) (n=3)
A
(i)
(ii)
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Figure 3.2 Dose dependency of sodium lactate in pregnant rat myometrium
A. Representative force recordings of spontaneously contracting myometrial strips during 
5 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM and (v) 20mM lactate.
A
(i)
(ii)
(iii)
(iv)
(v)
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Figure 3.3 Dose dependency of sodium lactate in pregnant rat myometrium
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to lactate. Using the dose-
response curve plotted using the AUC data, the IC50 value for lactate is 4.83mM. N 
numbers are denoted by values within bars. A significant difference in activity was found 
using ANOVA with Bonferroni * denotes p<0.05 **p<0.01 ***p<0.001 significance.
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Figure 3.4 The effect of 5mM lactate on spontaneous rat myometrium
A. Representative paired isometric recordings of contracting myometrial strips in the 
presence of  5mM lactate. Out of 8 myometrial strips tested, 4 continued contracting 
under lactate (i) and in 4 strips contractions were abolished (ii).
A
(i)
(ii)
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Table 3.1 Changes in contractility in response to 1-20mM sodium lactate in term 
pregnant rat myometrium
Term (within 24 hours of labour) rat myometrial strips were used from 7-8 animals. 
Control baseline contractions were obtained 5minutes before lactate application. Tissue 
strips were superfused with the solutions indicated for 5 minutes. The parameters of 
contractions were re-measured and expressed as a percentage of control values (i.e. 
Paired) for the last two minutes of lactate application. Frequency is for the total 5 minute 
application. Values are means ± standard error of the mean (S.E.M.)
* represents significant differences in contractility compared to preceding control period 
p<0.05 **p<0.01 ***p<0.001 
Contractile
parameters
1mM lac
(% ± S.E.M.) 
n= 7
3mM  lac
(% ± S.E.M.) 
n= 8
5mM  lac
(% ± S.E.M.) 
n= 8
10mM lac
(% ± S.E.M.) 
n= 7
20mM lac
(% ± S.E.M.) 
n= 7
Amplitude 96% ± 10% 70% ± 15% 53% ± 16%* 19% ± 13%* 0% ± 0%*
Duration 98% ± 2% 86% ± 16% 90% ± 2%* 65% ± 9% N/A
Frequency 97% ± 1% 84% ± 14% 43% ± 12%** 36% ± 13%* 0% ± 0%**
A.U.C. 84% ± 11% 62% ± 14%* 35% ± 13%* 14% ± 10%** 0% ± 0%**
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3.4.2 Oxytocin-induced contractions 
To investigate if lactate can affect force under agonist stimulation, the effects of lactate on 
oxytocin-induced contractions were studied. 0.1nM oxytocin was added to PSS and applied 
to myometrial strips. This concentration was chosen as it caused an increase in force which 
could be sustained by the tissue and avoided tonic activity. 
 Increasing concentrations of lactate (1-40mM) were applied to contracting tissue. This 
produced a decrease in contractile activity as seen in spontaneous contractions (Figure 3.5, 
n = 3-6). However lactate in the presence of oxytocin and at concentrations previously used, 
did not abolish force (Figure 3.5 Ai-v). Only 40mM lactate abolished contractility (Figure 3.5 
Aiv). 
Amplitude, frequency and a.u.c. were significantly decreased at 20mM and 40mM, with 
duration and a.u.c. of 3mM lactate response also being significantly reduced (Paired 
students t-test, p<0.05). There were significant differences between concentrations and in 
all parameters (Figure 3.6 Ai-iv). The EC50 for lactate in the presence of oxytocin, taken from 
the a.u.c dose response curve, is 11.1 ± 1.7 mM (Figure 3.6 Aiv). Figure 3.7 compares the 
effect of 10mM lactate in both spontaneous and oxytocin-driven activity and the greater 
effect on spontaneous contractility is clearly seen. 
 Lactate affected contractility to a lesser extent than with spontaneously contracting tissue 
as shown by mean data (+s.e.m) in Figure 3.8. This was significant at 10mM lactate (Figure 
3.7) for amplitude (Figure 3.8 Ai), frequency (Figure 3.8 Aiii) and a.u.c (Figure 3.8 Aiv). The 
dose response curve for lactate +oxytocin, when plotted against spontaneous activity, is 
shifted to the right, indicating a higher EC50 value.  
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Figure 3.5 Dose dependency of sodium lactate in oxytocin-driven activity
A. Representative isometric recordings of contracting myometrial strips in the presence of 
oxytocin during 5 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM (v) 20mM 
(vi) 40mM lactate.
A
(i)
(ii)
(iii)
(iv)
(v)
(vi)
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Figure 3.6 Dose dependency of sodium lactate in oxytocin-driven activity
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to lactate. N numbers are 
denoted by values within bars. A significant difference in activity was found using ANOVA 
with Bonferroni. * denotes a significance p<0.05 **p<0.01
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Figure 3.7 A comparison of response to lactate in spontaneous and oxytocin activity
105 
 
 
0
50
100
Control 1mM 3mM 5mM 10mM 20mM
%
control
Duration
0
50
100
Control 1mM 3mM 5mM 10mM 20mM
%
control
Amplitude
0
50
100
Control 1mM 3mM 5mM 10mM 20mM
%
control
Frequency
Figure 3.8 A comparison of lactate response in spontaneous and oxytocin activity
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to lactate, when applied to 
spontaneously contracting term pregnant rat myometrial strips (red bars) and in the 
presence of 0.1nM oxytocin (blue bars). A significant difference in activity was found using 
Paired Samples T-Test *denotes p<0.05
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3.4.3 Comparative effects of other weak acids  
To determine if myometrial response were specific to lactic acid, three other weak acids 
were tested; butyric acid, propionic acid and pyruvic acid at 5mM concentration. These 
weak acids have pKa values (log quantitative measure of strength of an acid in solution) of 
4.87 (propionic acid) 4.82 (butyric acid) and 2.50 (pyruvic acid). These are similar to lactate 
which has a pKa of 3.86. 
These weak bases were also applied to spontaneously contracting tissue for 5 minutes after 
a control period. The three weak acids were found to produce effects similar to that of 
lactate: a decrease in force (Figure 3.9).  Contractions under sodium propionate (n=6) 
sodium butyrate and sodium pryuvate (n=3) decreased in amplitude (Figure 3.9 Ai), duration 
(Figure 3.9 Aii), frequency (Figure 3.9 Aiii) and A.U.C. (Figure 3.9 Aiv). There was no 
significant difference between these weak acid responses. Because of this, only one weak 
acid (sodium propionate) was used to repeat the full range of concentrations used in the 
previous lactate experiment in Chapter 3.4.1. 
 1-20mM propionate was applied to spontaneously contracting tissue and there was a dose-
dependent decrease in force (n=6) (Figure 3.10 A). 10mM and 20mM propionate was 
significantly reduced when compared to control (100%) in all four parameters. Frequency 
under 3mM and 5mM propionate was significantly reduced (58.5% ± 16.3% p=0.03, 36.3% ± 
18.6% p=0.01 respectively, students paired t-test). Force amplitude was also significantly 
reduced in 1mM propionate (92.5% ± 2.6% p=0.025) Mean data for all four parameters 
shows there were significant differences between concentrations (Figure 3.11 Ai-iv). The 
EC50 for propionate on spontaneous tissue, measured from the dose-response curve, is 
3.2±0.9 mM (Figure 3.11 Aiv).  
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Figure 3.9 A comparison of weak acids
A. Representative traces for 5 minute application of four weak acids tested.
B. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to 5mM sodium butyrate (purple 
bars), sodium propionate (green), sodium lactate (red) or sodium pyruvate (blue), when 
applied to spontaneously-contracting term pregnant rat myometrial strips. N numbers are 
denoted by values within bars. There was no significant difference between the weak acid 
responses.
(i)
(ii)
(iii)
B
A
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Figure 3.10 Dose dependency of sodium propionate in pregnant rat myometrium
A. Representative isometric recordings of spontaneously contracting myometrial strips 
during 5 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM and (v) 20mM 
propionate.
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Figure 3.11 Dose dependency of sodium propionate in pregnant rat myometrium
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to propionate. N numbers are 
denoted by values within bars. A significant difference in activity was found using ANOVA 
with Bonferroni. * denotes a significance p<0.05 **p<0.01
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Propionate was also tested on oxytocin-driven activity (Figure 3.12 and 3.13). This reduced 
contractions in all preparations (n=3-6) and this response was similar to lactate under 
oxytocin stimulation. Amplitude, duration, frequency and a.u.c. were significantly decreased 
at 20mM, with duration and a.u.c. of 10mM lactate and duration of contractions in 3mM 
lactate also being significantly reduced (Paired students t-test, p<0.05). The EC50 for 
propionate under oxytocin is 9.6±1.1 mM (Figure 3.13 Aiv).  
Mean data for lactate and propionate was plotted together to compare the two weak acid 
responses. There is no significant difference between lactate and propionate on 
spontaneous activity, in amplitude (Table 3.2 Ai), duration (Table 3.2 Aii), frequency (Table 
3.2 Aiii) or a.u.c. (Table 3.2 Aiv). There was also no significant difference in responses 
between propionate and lactate in the presence of oxytocin for all parameters (Table 3.3). 
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Figure 3.12 Dose dependency of sodium propionate in oxytocin-driven activity
A. Representative isometric recordings of contracting myometrial strips in the presence of 
oxytocin during 5 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM (v) 20mM 
(vi) 40mM propionate.
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Figure 3.13 Dose dependency of sodium propionate in oxytocin-driven activity
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to propionate. N numbers are 
denoted by values within bars. A significant difference in activity was found.
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Table 3.2 A comparison of lactate and propionate response in spontaneous activity
A. Mean data ± s.e.m. showing dose-dependent decrease in (i) amplitude (ii) duration (iii) 
frequency  and (iv) AUC in response to lactate and propionate, when applied to 
spontaneously contracting term pregnant rat myometrial strips. There was no significant 
difference between the two weak acids.
(iv) A.U.C.
Lactate Propionate P 
value
1mM 96.0±2.0% 76.5±15.5% 0.28
3mM 69.8±15.3% 68.9±17.3% 0.90
5mM 47.3±15.3% 57.3±18.3% 0.68
10mM 19.5±12.7% 31.6±20.3% 0.78
20mM 0 5.0±0% -
Amplitude
Lactate Propionate P 
value
1mM 98.3±2.2% 78.5±16.0% 0.36
3mM 86.2±15.9% 89.2±6.3% 0.88
5mM 90.5±2.2% 85.6±4.8% 0.07
10mM 65.3±9.1% 100. 0±0% 0.19
20mM 0 67.1±0% -
Duration
Lactate Propionate P 
value
1mM 96±2% 76.7±17.4% 0.20
3mM 80±20% 75.0±7.4% 0.67
5mM 39±13% 38.4±8.5% 0.58
10mM 33±15% 22.8±12.1% 0.71
20mM 0 19.6±8.5% -
Frequency
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Table 3.3 A comparison of lactate and propionate response in oxytocin-driven activity
A. Mean data ± s.e.m. showing dose-dependent decrease in (i) amplitude (ii) duration (iii) 
frequency and (iv) AUC in response to lactate and propionate, when applied to term 
pregnant rat myometrial strips in the presence of oxytocin. There was no significant 
difference between the two weak acids.
A
(i) (ii)
(iii) (iv)
A.U.C.
Lactate Propionate P 
value
1mM 96.7±0.8% 101.3±2% 0.18
3mM 95.0±1.9% 92.7±3.2% 0.45
5mM 75.6±19.1% 79.7±16.2% 0.87
10mM 69.5±14.2% 73.3±15.3% 0.86
20mM 30.4±21.5% 17.2±17.2% 0.63
Amplitude
Lactate Propionate P 
value
1mM 99..4±5.6% 100.2±2.2% 0.92
3mM 93.5±2.0% 82.8±2.8% 0.01*
5mM 92.5±1.2% 93.4±6.84% 0.88
10mM 79.9±3.8% 83.8±3.3% 0.87
20mM 89.6±12.1% 91.5±15.3% 0.56
Duration
Lactate Propionate P 
value
1mM 96.7±2.6% 101.0±2% 0.12
3mM 96.7±1.8% 87.9±10.2± 0.69
5mM 78.9±19.9% 74.5±15.5% 0.62
10mM 60.8±19.3% 56.0±17.8% 0.97
20mM 25.4±19.7% 1.0±0% 0.80
Frequency
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3.4.4 Mechanisms underlying the effect of lactate 
3.4.4.1 Intracellular pH 
Using the fluorescent indicator Carboxy-SNARF allows for the simultaneous measurement of 
intracellular pH (pHi) and force. Loading myometrial tissue with this indicator has been 
shown not to alter contractile activity (Taggart & Wray 1993a). The application of 5mM 
lactate to loaded myometrial strips, either spontaneously active or quiescent, altered the 
pHi (Figure 3.14). Lactate significantly decreased the internal pH by 0.13±0.01 pH units 
(n=10, p=0.002 Paired students t-test). Values obtained for those continuing to contract 
under 5mM lactate and those that stopped contracting were similar. When lactate was 
removed there was a rebound alkalinisation and pHi returned to control values. Increasing 
concentrations of lactate caused a significant dose dependent decrease in pHi (Figure 3.14): 
10mM caused a 0.19± 0.02 pH unit drop (n=5, p=0.02) and 20mM lactate decreasing pHi by 
0.24±0.03 pH unit drop (n=5, p=0.001). There was a significant difference between 5mM and 
20mM lactate (Figure 3.14).  
5mM lactate was applied in the presence of 0.1nM oxytocin (Figure 3.15). There are small 
notches in the baseline, in both spontaneous and oxytocin-driven activity, which represents 
normal acidification associated with contractions and has been shown in previous work 
(Taggart & Wray 1993b). Contractions reappear when lactate is removed and pHi increases. 
Lactate caused a pH drop of 0.09±0.01pH units (n=4, p=0.001) which was significantly 
different to the drop in spontaneous contractions (p=0.04, unpaired students t-test) (Figure 
3.15).   
5mM butyrate was used in some experiments as a reference marker, as this is a more widely  
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used and studied weak acid in pH experiments, and has been shown before to decrease pHi 
in the myometrium (Wray). Butyrate caused a similar drop in pHi to lactate (0.13±0.02 pH 
units, p=0.002) (Figure 3.16) which is in agreement with previously seen values (Taggart & 
Wray 1993b). This was not significantly different to the drop seen with 5mM lactate (p=0.98, 
students unpaired t-test) (Figure 3.16). 
To reinforce the theory that drop in pHi is causing the decrease in force; I used a weak base 
simultaneously with lactate to ‘null’ the pH change. Ammonium chloride is a commonly 
used weak base and has been shown previously to cause intracellular alkalinisation of the 
myometrium (Parratt, Taggart & Wray 1995b). 5mM NH4Cl was simultaneously applied with 
5mM lactate to spontaneously contracting pregnant rat myometrium for 5 minutes (n=2). As 
seen in Figure 3.17 A, contractions continued in the presence of the weak base and acid and 
pHi fluctuated only slightly. This effect on contractility is also seen using 5mM butyrate 
(Figure 3.17 B) 
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Figure 3.14 The effect of lactate on intracellular pH
All term pregnant myometrial strips were loaded with Carboxy-Snarf 1 AM, excited at 540nm and 
emitted fluorescence recorded at F590:F640.
A: Significant dose dependent decrease in pHi in response to 5mM, 10mM and 20mM sodium 
lactate (5 minutes). Force not shown (n=5-8).
B: Mean (+ s.e.m.) data for pH drop of lactate (5mM-20mM, red bars). N numbers are shown in 
their respective bars. There was a significant difference between 5mM lactate and 20mM lactate 
(p=0.002, unpaired students t-test)
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Figure 3.15 The effect of lactate on intracellular pH of oxytocin-driven contractions
A: Simultaneous recording of force and pHi in the presence of 5mM lactate (5 minutes) on 
spontaneous and oxytocin-driven activity (n=4). Small notches in baseline are associated with 
normal contractions. 
B: Mean (+ s.e.m.) data for pH drop of 5mM lactate on spontaneously active tissue (red bar) 
compared to the drop in the presence of 0.1nM oxytocin (blue bar).  N numbers are denoted by 
values within bars. The pH drop in oxytocin was significantly different  to spontaneous activity 
(p=0.042, unpaired student t-test) 
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Figure 3.16 The effect of lactate and butyrate on intracellular pH
A: 5mM butyrate decreased pHi  to the similar extent as lactate. Force not shown. (n=5)
B: Mean (+ s.e.m.) data for pH drop of lactate (5mM, red bar) and 5mM butyrate (purple 
bar). N numbers are shown in their respective bars. There was no significant difference 
between lactate and butyrate.
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Figure 3.17 pH null experiment using lactate and ammonium chloride
A: Simultaneous force and pHi measurements of spontaneously contracting term rat 
myometrium. 5mM lactate and 5mM ammonium chloride were applied simultaneously 
for 5 minutes (n=2). 
B: Force only measurements using 5mM sodium butyrate and 5mM ammonium chloride 
(n=2)
A
B
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3.4.4.2 Intracellular Ca2+ 
The effect of lactate on intracellular calcium signalling was investigated by using Indo-1 AM. 
7 strips were loaded and 5mM lactate applied for 5minutes. 3/7 of strips continued 
contracting in the presence of lactate and were used in statistical analysis. In the presence 
of lactate, calcium transients decreased in amplitude (88.8%± 2.6%) (Figure 3.18 A). This was 
mirrored in the force. Once abolished, transients (and therefore contractions) were 
inhibited throughout lactate application. Calcium transients reappeared when lactate was 
removed with increasing amplitude and this was reflected in the force measurements, 
which returned to previous control levels. Duration (in the last two minutes of lactate 
application) and frequency (in the total application) of calcium transients were significantly 
decreased when compared to control contractions (100%): Duration to 79.5 ±2.0% (p=0.01); 
frequency to 77.8±0.6% (p=0.01). Amplitude was not significantly reduced (p=0.12). Further 
analysis of the last contraction under lactate, when compared with control, shows the 
decrease in duration is due to the number of spikes present in the calcium transient (Figure 
3.18 B). Calcium spikes are caused by calcium entry triggered by individual action potentials 
and triggers phasic contraction (Burdyga, Wray & Noble 2007). The mean number of spikes 
present in the transient significantly falls from 20±6 to 13±5 in the presence of lactate (n=3, 
p>0.05) 
In order to determine if the effects of lactate were due to inhibition of L-type Ca2+ channels, 
Bay K-8644, a  Ca2+ channel agonist  was applied to spontaneously contracting tissue (n=6). 
In all preparations application of Bay K-8644 stimulated spontaneous contractions (Figure 
3.19 A) consistent with its ability to increase the opening probability of L-type Ca2+ channels 
(Yoshino, Nishio & Yabu 1988). 5mM Lactate was applied in the presence of Bay K-8644 for 
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10minutes. This had a small but significant effect on contractility as shown in the mean data 
(Figure 3.19 B) when compared to preceding contractions in Bay K-8644 (control 100%). 
Note the x-axis on the graph starts at 85%. Duration of contractions significantly decreased 
to 92.5±1.9% (p=0.01 paired students t-test) and overall A.U.C. decreased to 93.9±2.3% 
(p=0.04). Amplitude and frequency of contractions were not significantly altered (99.7±0.7% 
p=0.73, 100.9±2.2% p=0.69 respectively) 
When compared to the effect of lactate on spontaneous activity, amplitude frequency and 
a.u.c increased in the presence of lactate and Bay K8644 when the last 2 minutes of activity 
were compared. Amplitude was significantly increased by 110.7% (p=0.01, Student unpaired 
t-test), frequency increased by 139.4% (p=0.01) and a.u.c. by 150.6% (p=0.03). Duration of 
contractions did not differ (p=0.84). 
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Figure 3.18 Effect of lactate on intracellular Ca2+ signalling in the myometrium
A. Simultaneous force and intracellular Ca2+ recording, using Indo-1 AM, in spontaneously 
contracting rat myometrium in the presence of 5mM lactate. Emitted fluorescence is 
shown as F400:F500 (n=3).
B. The last contraction in the control period (black line) overlaid with the last contraction 
in the presence of lactate (grey line) with the corresponding intracellular Ca2+ signal (red 
and blue respectively)
A
B
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Figure 3.19 The effect of lactate in the presence of Bay K8644, a Ca2+ channel agonist
A. A representative force trace to show 5mM lactate (10 minutes) effect on spontaneously 
contracting tissue in comparison to its effect in the presence of  0.1 µM Bay K8644.
B. Mean data (± s.e.m.) for all four contractile parameters analysed before (blue bar) and 
during (red bar) lactate application. (n=6). There was a significant difference in duration 
and overall a.u.c. of contractions with lactate.
A
B
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3.4.4.3 KCl  
Lactate was applied to depolarised myometrium. The depolarization was produced by 
applying 40mM KCl solution. These experiments were performed to investigate if the effects 
of lactate are beyond surface membrane excitability i.e. can lactate still reduce force if the 
membrane is held depolarized and Ca2+ entry maintained?  
Application of KCl solution produced a rapid increase in force (to the peak amplitude) which 
then declined to a level and plateau throughout the application of solution (Figure 3.20). 
This was a repeatable response that was seen in all preparations and there was no 
difference between peak amplitudes or a.u.c. of all KCl responses (n=8, p=0.7 unpaired t-
test) (Figure 3.20 B). 10mM lactate, in the presence of KCl, was applied after 2.5mins of KCl 
application for 5 minutes (n=6) (Figure 3.20 A). Force in the presence of lactate was, 
surprisingly, significantly increased by 18.9±4.5 % when compared to force at 2.5minutes, 
directly before lactate was applied (p=0.044, unpaired t-test). Force decreased when lactate 
was removed and returned to basal levels when KCl was removed. However the a.u.c. did 
not reach significance with lactate (p=0.54) Simultaneous Ca2+ measurements show an 
increase in intracellular Ca2+ when lactate is applied. 
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Figure 3.20 Effect of lactate on Ca2+ entry 
Depolarisation of the membrane using 40mM KCl (10 minutes) in term pregnant 
myometrial strips loaded with Indo-1 AM. 
A. Simultaneous force and intracellular Ca2+ recording of the effect of 10mM lactate in the 
presence of KCl after an initial 10minute application of KCl. (n=6)
B. KCl was applied for 10 minutes after the first KCl application as a control. (n=2)
A
B
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3.4.5 Gestational dependent effects of lactate  
The above data were all obtained on late-pregnant myometrium. To investigate if the 
lactate data were specific to the animal being close to labour, I investigated if the effect of 
lactate changed during pregnancy or with the onset of labour. Lactate was applied to 
spontaneously contracting myometrial strips from rat uterus at varied gestational states; 
non-pregnant (n=6), 11day pregnant (n=4), 18day pregnant (n=6), term pregnant (n=8) and 
labouring myometrium (n=5) (Figure 3.21).  
After a control period of 10minutes spontaneous activity, 5mM lactate was applied 
extracellularly to tissue strips for 10minutes (Figure 3.21 A). This was in contrast to previous 
experiments as the frequency of contractions in non-pregnant and 18d tissue was low i.e. ≤2 
contractions in 5 minutes. A longer application time was used to allow the full effect of 
lactate on frequency to be seen. In analysis of contractility, amplitude, duration and A.U.C. 
were measure from the last 5 minutes of application. This is so the data can be compared to 
term pregnant rat tissue that was exposed to 5 minutes of lactate in Chapter 3.4.1. The last 
2 minutes of lactate in term tissue was used in analysis.  
Lactate had little effect on non-pregnant and 11day myometrium (Figure 3.21 Ai, Aii 
respectively). As gestation progressed to term, lactate had increasing effects on contractility 
(Figure 3.21 Aiii-iv). At 18day gestation, 5mM lactate had a significant effect on force 
amplitude (34.8±21.4% p=0.05) and frequency (47.4±10.0%, p=0.04).   After labour was 
initiated, surprisingly, lactate had little effect on contractility, similar to non-pregnant tissue 
(Figure 3.21 Av). Mean data shows amplitude, duration, frequency and a.u.c. reduced under 
lactate at gestations >11day until labour onset (Figure 3.21 B).  
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Figure 3.21 The effect of lactate on rat myometrium throughout gestation
A. Representative isometric recordings of spontaneously contracting myometrial strips 
from (i) non-pregnant (ii) 11d gestation (iii) 18d gestation (iv) term pregnant and (v) 
labouring uterus during 5 minutes application of lactate.
B. Mean data ± s.e.m. (denoted by error bars) for (i) amplitude (ii) duration (iii) Frequency 
and (iv) A.U.C. for all gestations. N numbers are denoted by values within bars. A 
significant difference in activity was found using Anova with Bonferroni. * denotes p<0.05 
significance.
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There was a significant difference in amplitude (Figure 3.21 Bi), frequency (Figure 3.21 Biii) 
and a.u.c (Figure 3.21 Biv) between gestations (p>0.05, Anova with Bonferroni post-hoc 
test). 
When comparing 5mM lactate response between non-pregnant myometrium and term 
pregnant myometrium, there was a significant difference in amplitude (p=0.02, unpaired 
students t-test) and a.u.c. (p=0.05) (Figure 3.22 Ai and iii respectively).  There was no 
significant difference in duration (p=0.10) or frequency (p=0.08).  
There was a significant difference in response to 5mM lactate between term pregnant 
myometrium and labouring tissue. Contractions under lactate were significantly increased in 
labouring myometrium (99.7%±4.8% when compared to term-pregnant 100%) (p=0.02) and 
overall a.u.c. was increased to 167.5%±6.6% (p=0.01). Amplitude, although not significant, 
was increased in labouring tissue (p=0.09). There was little difference in duration between 
the two tissues (labouring tissue 6.5%±5.4% larger duration than term, p=0.36). I performed 
a dose-response experiment on labouring tissue and found higher concentrations were 
needed to abolish contractions (n=2) (Figure 3.22 A). To investigate why there was a 
dramatic difference between these two gestations, I loaded labouring myometrial strips 
with Carboxy-Snarf to investigate intracellular pH (n=2) (Figure 3.23 B). Figure 3.23 Bi shows 
how, in the presence of lactate, there is a drop in pHi and contractions continue. When this 
drop is compared with that seen in term pregnant tissue, it appears the drop is less 
significant (0.09±0.02) (Figure 3.23 Bii). Repeat experiments are needed before statistical 
analysis can be performed. 
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Figure 3.22 Comparison of response to 5mM lactate between non-pregnant and 
pregnant myometrium.
A. Mean data (± s.e.m.) for (i) amplitude (ii) duration (iii) frequency and (iv) A.U.C. for non-
pregnant  myometrium (blue bar) and term pregnant myometrium (purple bar). N 
numbers are denoted in the relevant bars. * denotes p<0.05 significance value found by 
unpaired students t-test.
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Figure 3.23 The effect of lactate on intracellular pH of labouring rat myometrium
A: Force recording  of the application of lactate spontaneously contracting labouring 
myometrium for 10 minutes (5mM-20mM) (n=2).
B: (i) Simultaneous force and pHi measurement of the effect of 5mM lactate (5 minutes 
application) on labouring rat myometrium.
(ii) Mean (+ s.e.m.) data for pH drop of 5mM lactate on spontaneously active tissue 
(purple bar) compared to the drop on labouring tissue (turquoise bar).  N numbers are 
denoted by values within bars. 
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3.5 Discussion 
Previous work has indicated lactate may play a role in dysfunctional labour; however no 
previous functional studies have investigated the effect of lactate on myometrial 
contractility. This study shows that the application of lactate and other weak acids to rat 
myometrium causes a decrease and, at high enough concentrations, a cessation of 
contractions. The response seen is not specific to lactate; other weak acids produce a similar 
decrease and cessation of contractility, on both spontaneous and oxytocin-driven activity. 
Therefore the effect seen with lactate is not due to its role in metabolism. The effect of 
lactate throughout gestation is not consistent; its effects are greater closer to term and 
lactate has little effect on labouring tissue. Loading with the fluorescent indicators Carboxy-
SNARF and Indo-1 have confirmed that lactate causes the intracellular pH of the 
myometrium to fall and calcium transients are affected. Depolarisation of myometrial tissue 
with KCl solution indicates lactate may affect membrane potential.  
Lactates ability to induce relaxation of vascular smooth has previously been documented. 
There is also agreement that lactate causes a significant decrease in pHi. Although my data 
shows a similar concept, I found EC50 value of ~5mM, whereas other groups have seen used 
>10mM (Barron & Nair 2003), with one group finding an EC50 value of 26mM (McKinnon et 
al. 1996). However this could be due to tissue-specific differences. 
The reason for lactates effect on term pregnant tissue could be an in-built mechanism to 
prevent excessively powerful tonic-like uterine contractions during labour, which could 
clamp down blood vessels and reduce blood flow (and therefore oxygen) to the fetus and 
cause fetal distress. Reduced blood flow also reduces the ability to clear lactate and H+, thus 
causing a decrease in pHi. As lactate (and H
+) levels increase in the myometrium, L-type Ca2+ 
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channels are inhibited (Figure 3.24). It is known that H+ displacement affects L-type calcium 
channel (Klockner & Isenberg 1994). H+ and Ca2+ are cations and therefore there may also be 
competition between the two ions at intracellular binding sites. H+ could displace Ca2+ 
bound to myofilaments and therefore decrease tone. As Ca2+ levels in the myometrial cell 
are reduced or displaced from the myofilaments, contractility is abolished and restriction to 
blood flow is removed. Blood flow to the myometrium is restored and lactate, through its 
transporters, can leave the cell down its concentration gradient. Once lactate levels have 
been reduced, L-type Ca2+ channels are no longer inhibited by protons, and Ca2+ entry is 
restored and with it,  contractions.  
Non-pregnant and early pregnant myometrium appear to be resistant to the effects of 5mM 
lactate compared to late-pregnant tissue. This could be due to differences between the 
myometrium, suggested in Figure 3.25. The expression of transporters may be up regulated 
towards term, allowing for the eventual increase in both aerobic and anaerobic respiration 
in labour. The levels and activity of lactate dehydrogenase (the enzyme responsible for the 
production/oxidation of lactate) may also be altered. There was surprisingly little inhibitory 
effect of lactate on labouring myometrium, especially compared to the effects seen in late 
pregnant rats. Higher concentrations of lactate are needed to affect labouring tissue. Initial 
experiments loading labouring tissue with Carboxy-Snarf suggests 5mM lactate does not 
cause the same pHi drop as seen in late pregnant tissue. This may be due to increased 
buffering power in labouring myometrium (Figure 3.25). However further experiments are 
needed to confirm this. The mechanism of how lactate is acting on the myometrium, 
suggested previously in this chapter, may also not be applicable in this animal model due to 
differences in the duration of labour. Experiments  
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Figure 3.24 Suggested mechanism of action for lactate in term pregnant tissue
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Figure 3.25 Suggested differences between late-pregnant and non-pregnant/ 
labouring myometrium
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need to be carried out on human myometrium, in particular labouring myometrium, to see 
if this mechanism can be elucidated.  
KCl is used to directly open L-type Ca2+ channels. Lactate did not significantly reduce force in 
the presence of KCl, indicating its effects are via these channels. The increase in force when 
lactate was applied indicates it is able to increase cytosolic free Ca2+. This is possibly due to 
Ca2+ release from the mitochondria (Pierce 2003). 
When lactate is removed, pHi rises. There is a rebound alkalinisation due to mechanisms 
that restore resting pH and because of this the frequency and amplitude of contractions 
increase to above control levels. When the resting pH is reached, contractions return to 
control values. In rat myometrium, oxytocin has some rescue effect when a weak acid is 
applied. This is more noticeable at higher acid concentrations (10mM and 20mM). In 5mM 
lactate the drop in pHi is significantly reduced. Oxytocin can increase intracellular [Ca
2+] by 
stimulating Ca2+ entry, releasing Ca2+ from the SR and decreasing Ca2+ efflux from the cell. 
(Soloff & Sweet 1982; Wray 2007). Oxytocin has also been shown to sensitise myofilaments 
to Ca2+ (Somlyo & Somlyo 1998). However it is not enough to overcome the fall in pH caused 
by lactate application and contractions are still affected. This is seen clinically where 
administration of oxytocin does stimulate a dysfunctional- contracting uterus in all cases. 
The response of the myometrium to 5mM lactate needs to be investigated further. The 
reasons for some tissue strips continually contracting under lactate and others being 
abolished is unclear. This response could also be due to the natural variability of myometrial 
tissue-perhaps there are differences in LDH levels or MCT expression in these tissues 
therefore effecting lactate entry into the myometrial cell and its movement and breakdown. 
As every care was taken to dissect strips of similar size and weight, variation in dissection of 
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these tissue strips is unlikely to be a factor.  
 In the rat myometrium, an initial increase in force of contraction is produced when lactate 
is applied.  More investigation is need but an initial theory may be that Ca2+ increase when 
lactate applied or the activation of ASIC channels by the increase in H+. Further work 
includes the calibration of Carboxy-SNARF emission ratios to obtain actual pH values of the 
myometrium and to analyse how much the pH changes when lactate is added. 
In summary, the data in this chapter shows the effect of lactate on rat myometrial 
contractions and how its effects are most potent at term, possibly as a natural failsafe 
mechanism if contractions become too strong or powerful. Future investigations into the 
transporters and enzymes involved in the lactate response will shed further insight. 
 
3.5.1 Limitations of study 
- There is no direct evidence of an effect on calcium channels. This would need to be 
addressed in future work. 
 
3.6 Summary 
Lactate in the physiological range potently decreased spontaneous contractility in rat 
myometrium. Lactate also decreases oxytocin-stimulated contractions but its sensitivity was 
decreased. Lactate caused a larger decrease in pHi in spontaneously-contracting term 
pregnant myometrium than oxytocin-stimulated activity or labouring myometrium 
indicating the reason for the decrease in lactate sensitivity in these tissues. Lactate inhibited 
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Ca2+ transients, which could be due to a fall of intracellular pH as shown in previous studies. 
I suggest this is the mechanism whereby lactate and similar weak acids reduce myometrial 
contractions. 
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Chapter 4 
The effect of lactate on human myometrial contractility 
4.1 Abstract 
Labour dystocia accounts for 20% of all caesarean sections (CS) in the UK. The only 
treatment available is application of oxytocin, which only works in around 50% of cases. 
Lactate has been shown to be significantly increased in myometrial capillary blood 
during labour dystocia suggesting it may be impairing force production, but there are no 
functional data on the effect of lactate on the myometrium. Therefore I have 
investigated its effect on contractility of human myometrium.  
Myometrial strips were taken from biopsies obtained (following written informed 
consent) from women undergoing either a caesarean section (CS) at term (pregnant) or 
a hysterectomy (non-pregnant). The effects on spontaneous contractility in response to 
sodium lactate and sodium propionate (1-20mM) were recorded. Oxytocin-stimulated 
contractions (0.5nM) were also investigated to increase the physiological and clinical 
relevance of data obtained. Statistical differences were tested using appropriate tests 
and significance taken as p<0.05. 
 Lactate significantly decreased spontaneous contractility (n=5-6). A dose dependent 
decrease in all contractile parameters was seen, relative to the preceding control period. 
Propionate also significantly reduced contractions in a dose-dependent manner. There 
was no significant difference in the effects of these weak acids on human myometrium. 
The effects of lactate were significantly reduced in the presence of oxytocin (n=4-6). 
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When compared to spontaneous contractility, there was a significant difference at 
10mM in amplitude (p=0.01) and frequency of contractions (p=0.04). Non-pregnant 
myometrium was resistant to lactate: 5mM lactate significantly decreased duration and 
overall a.u.c of contractions in spontaneously-contracting non-pregnant tissue. 
Amplitude and frequency of contractions were not significantly affected.  
Lactate potently decreases human myometrial contractility. The effects of lactate 
were reduced in the presence of oxytocin. Another weak acid, propionate, produced 
similar effect to lactate. I suggest accumulation of extracellular lactate, which as I have 
shown, will reduce myometrial contractions, could therefore contribute to labour 
dystocia. 
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4.2 Introduction 
For successful labour to occur the uterus needs to produce strong coordinated contractions. 
The processes and pathways that achieve this are well characterised, as detailed in Chapter 
1. However when contractions are weak and uncoordinated, labour cannot progress 
successfully. Dysfunctional labours (or dystocia), in particular those due to inefficient 
uterine activity in the first stage, are common but there are limited therapeutic options 
available to these women. The administration of oxytocin only works in 50% of all cases 
(Wray 2007) and because of this, dysfunctional labour is a frequent cause of non-elective 
caesarean sections (Thomas J. 2001). Oxytocin has not reduced the number of sections in 
the UK (Bugg, Siddiqui & Thornton 2013). Caesarean sections are associated with increased 
morbidity for mother (Saunders, Paterson & Wadsworth 1992). 
Our group have previously shown that there is increased lactate in myometrial capillary 
blood from women suffering dysfunctional labour and that this blood is of a reduced pH 
(Quenby et al. 2004). In the myometrium, both intracellular and extracellular pH changes 
occur during labour due to vascular occlusion at the peak of uterine contraction (Wray et al. 
1992) and it has already been shown that intracellular acidification of human myometrial 
strips can affect contractility and it has been demonstrated to inhibit L-type Ca2+ channels 
(Pierce et al. 2003).  
There are no data that examines the functional effect of lactate on human myometrial 
contractility. Lactate has been shown to be produced by cultured myometrial cells (Akerud, 
Ronquist & Wiberg-Itzel 2009) but its effect on contractility has not been investigated. The 
aims of the study were: 
x) To investigate the effect of lactate on spontaneous contractile activity in human  
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myometrial contractility 
xi) to compare the effect of lactate under oxytocin-driven contractions 
xii) to compare the effects of another weak acid, propionate on spontaneous and 
oxytocin-driven contractions 
xiii) to investigate the effect of lactate on non-pregnant human myometrium  
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4.3 Methods 
4.3.1 Tissue 
Human myometrium was obtained from women undergoing elective lower segment 
caesarean section at term (34-41 completed weeks) or hysterectomy at Liverpool Women’s 
hospital with local ethical committee approval and written, informed consent. Non-
pregnant biopsies were taken from the lower part of the anterior wall of the uterus, to 
correspond with the pregnant biopsy area.  
A total of 42 samples were used in this study. The reasons for section included previous 
traumatic vaginal delivery (8) or previous CS (23), breech (8) and patient choice (3). Those 
who had failed IOL or who had commenced labour at the time of section were not included. 
4 women were prescribed inhalers for asthma.  The mean age of women undergoing 
caesarean delivery was 32 years old (range 22- 44 years), mean BMI of these women was 
27.3(range 18.0- 50.7) and the mean gestation was 38 completed weeks. The mean parity 
was 1 (range 0- 4).  
For non-pregnant tissue, those that were on medication, those that had abnormal smears or 
were having hysterectomies for endometriosis were excluded from this study. A total of 6 
non-pregnant samples were used. Indications for surgery included menorrhagia (4) fibroids 
(1) and ovarian cancer prevention (1). The median age of women was 43 years old (range 
34- 49 years), the median BMI was 28.0 (range 21.2- 30.8) and the median parity of these 
women was 2 (range 0- 4). 
1mm x 5mm human myometrial strips were dissected from myometrial biopsies. Individual 
strips were mounted between a fixed support and force transducer using aluminium clips in 
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a 1ml bath and were continuously superfused with PSS at a rate of 2mL/min and maintained 
at 37oC. Contractile activity was seen in all myometrial strips within 3 hours. Stable 
contractions were observed for 60 minutes before an experiment begun. Force was 
recorded as described in detail in Chapter 2. 
4.3.2 Solutions 
All solutions were created as described in Chapter 2. Physiological saline solution was 
composed of NaCl 154mM, KCl 5.6mM, MgSO4 10.9mM, Glucose 8mM, CaCl2 2mM at pH 
7.4. 40mM high K+ solution was used to test tissue viability and provide maximal activity. 
Oxytocin was used at a concentration of 0.5nM in PSS. 20mM Lac solution was made and 
diluted in PSS to provide 1mM-10mM solutions. Other weak acid solutions were made in the 
same way. 
4.3.3 Statistics 
Data was analysed using Origin 8.6 (Microcal) and n is the number of myometrial tissue 
strips from different animals. Amplitude and duration of each contraction was measured 
and the average in the 20 minutes of solution application was used. Frequency was 
measured as number of contractions within 20 minutes. If there were no contractions 
during lactate application, amplitude and frequency were recorded as ‘0’ and excluded from 
duration analysis. Integral force (AUC) was measured during 20 minutes of solution 
application or control period. All data is presented as % of control period (100%). Normality 
tests were carried out on the data and the appropriate statistical tests used in SPSS Statistics 
20. Significance was taken as P<0.05. 
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4.4 Results 
4.4.1 Dose response of lactate on human myometrium 
As an increased amount of lactate has been suggested as a cause of dysfunctional labour, 
the effect of lactate on human myometrial contractility was tested. Tissue strips were able 
to produce stable, regular contractions for many hours. A 20 minute application time was 
chosen as the average time for 4 contractions (Figure 4.1). 1-20mM sodium lactate was 
applied extracellularly for 20 minutes and the effects on contractility determined (n=4-6) 
(Figure 4.2). Lactate caused a reduction and abolition of contractile activity and this 
response was dose dependent (Figure 4.2 Ai-v). Contractions reappeared when lactate was 
removed and the myometrium returned to PSS. There was a significant decrease in 
contractile parameters- amplitude, frequency and A.U.C. of contractions in the presence of 
lactate when compared to the preceding control period (Paired students t-test, p<0.05). 
Amplitude of contractions were significantly reduced at 20mM (p=0.04). Frequency and 
a.u.c of contractions were significantly affected at 3mM lactate and higher. There was no 
significant difference between duration of contractions in the presence of lactate. When 
comparing mean data (Figure 4.3) there was a significant difference in amplitude (Figure 4.3 
Ai) duration (Figure 4.3 Aii) and a.u.c (Figure 4.3 Aiii) between lactate concentrations (Anova 
with Bonferroni Post-hoc test, p<0.05). From the dose response curve plotted from a.u.c 
data, the EC50 of lactate on human spontaneous contractions is 3.8mM (± 1.4mM).  
It can also be seen that there was a dose-dependent drop in baseline tension seen in human 
myometrium (Figure 4.4). This was measured as the difference between the lowest point 
during lactate was compared to the baseline during control contractions. This drop was 
significant for concentrations ≥ 3mM (Paired student t-test, p<0.05).  Baseline and 
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spontaneous force returned to control levels upon removal of lactate. 
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Figure 4.1 The effect of sodium lactate in pregnant human myometrium
A: Isometric recording of the application of 5mM lactate to spontaneously contracting 
human myometrium for 20 minutes (i) and a paired tissue strip exposed to PSS for the 
same length of time (ii) (n=7)
A
(i)
(ii)
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Figure 4.2 Dose dependency of sodium lactate in pregnant human myometrium
A. Representative force recordings of spontaneously contracting myometrial strips during 
20 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM and (v) 20mM lactate.
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(v)
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Figure 4.3 Dose dependency of sodium lactate in pregnant human myometrium
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) AUC in response to lactate. Using the dose-response curve 
plotted using the AUC data, the EC50 value for lactate is 4.83mM. N numbers are denoted 
by values within bars. A significant difference in activity was found using ANOVA with 
Bonferroni post-hoc test * denotes p<0.05 **p<0.01 ***p<0.001 significance.
A
(i)
(ii)
(iii)
(iv)
*
**
*
**
**
**
***
*
***
***
**
A.U.C.
151 
 
 
Figure 4.4 Drop of baseline tension in the presence of lactate
A dose dependent drop in baseline tension of spontaneously contracting human 
myometrium in response to 1mM (blue bar) 3mM (red) 5mM (green) 10mM (orange) and 
20mM lactate (purple). N numbers are denoted by values within bars.
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4.4.2 Oxytocin-induced contractions 
The administration of oxytocin is used clinically to augment contractions in labour (Bernal 
2001) and this is seen in vitro. To investigate if lactate can affect force under agonist 
stimulation, the effects of lactate on oxytocin-induced contractions were studied. 0.5nM 
oxytocin was added to PSS and applied to myometrial strips (Figure 4.5). This concentration 
was chosen as it caused an increase in force which could be sustained by the tissue and 
avoided tonic activity and has been used in previous experiments in our laboratory 
(Robinson & Wray 2012). 
The response to lactate (1-20mM) when applied to contracting myometrium, in the 
presence of oxytocin, was a decrease in contractility (Figure 4.6 Ai-v). This is similar to what 
was seen during spontaneous activity in previously. When compared to the adjacent control 
period, frequency of contractions were significantly decreased at ≥5mM (Students paired t-
test, p<0.05). The a.u.c. was significantly reduced in all concentrations used. There was no 
significant difference in amplitude or duration of contractions. There were significant 
differences between lactate concentrations and in amplitude, frequency and a.u.c (Figure 
4.7 Ai, iii, iv). The EC50 for lactate in the presence of oxytocin, taken from the a.u.c dose 
response curve, is 5.4mM ± 1.2mM (Figure 4.7 Aiv).  
The drop in baseline tension seen with lactate on spontaneous activity is still seen in the 
presence of oxytocin (Figure 4.8). This drop in tension was significant at lactate 
concentrations of ≥5mM (paired students t-test, p<0.05). There was no significant difference 
between the drop in tension in spontaneous activity or oxytocin-driven contractions.  
Figure 4.9 compares the effect of lactate between spontaneous and oxytocin-driven activity. 
As shown by the mean data (+s.e.m) there is a significant difference at 10mM lactate in 
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amplitude (p=0.01) and frequency (p=0.04) of contractions (Figure 4.9 Ai and iii 
respectively). There is no difference between duration and a.u.c of contractions. The dose 
response curve for lactate +oxytocin, when plotted against spontaneous activity, is shifted 
to the right, indicating a higher EC50 value. 
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Figure 4.5 The effect of oxytocin on contracting human myometrium
Isometric recording of the application of 0.5nm oxytocin to spontaneously contracting 
human myometrium.
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Figure 4.6 Dose dependency of sodium lactate in oxytocin-driven activity
A. Representative isometric recordings of contracting myometrial strips in the presence of 
0.5nM oxytocin during 5 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM (v) 
20mM  lactate.
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Figure 4.7 Dose dependency of sodium lactate in oxytocin-driven activity
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) AUC in response to lactate. N numbers are denoted by values 
within bars. A significant difference in activity was found using ANOVA with Bonferroni 
post-hoc test * denotes p<0.05 **p<0.01 ***p<0.001 significance.
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Figure 4.8 Drop of baseline tension in the presence of lactate and oxytocin
A dose dependent drop in baseline tension of oxytocin-driven  (0.5nM) contracting human 
myometrium in response to 1mM (blue bar) 3mM (red) 5mM (green) 10mM (orange) and 
20mM lactate (purple). N numbers are denoted by values within bars.
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Figure 4.9 A comparison of lactate response in spontaneous and oxytocin activity
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) AUC in response to lactate, when applied to spontaneously 
contracting term pregnant non-labouring human myometrial strips (red bars) and in the 
presence of 0.5nM oxytocin (blue bars). A significant difference in activity was found using 
Paired Samples T-Test *denotes p<0.05
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4.4.3 Comparative effects of sodium propionate  
Sodium propionate was used to test the specificity of the lactate response in human tissue. 
1-20mM propionate was applied to spontaneously contracting myometrial strips for 20 
minutes and contractile parameters measured (n= 4-6) (Figure 4.10 Ai-v).  Contractions were 
reduced in a dose-dependent manner, as seen with lactate, which returned to control 
values when in PSS. There was a significant difference in amplitude of contractions in 1mM 
lactate (Paired students t-test). Frequency and a.u.c. were significantly reduced at 
concentration ≥3mM. There was no difference in duration of contractions in the presence of 
propionate. As shown in Figure 4.11, there is a significant difference between propionate 
concentrations when observing amplitude (Figure 4.11 Ai) frequency (Figure 4.11 Aii) and 
a.u.c. (Figure 4.11 Av). The EC50 for propionate in spontaneously contracting human 
myometrium is 3.9mM ± 1.2mM. 
There was also a dose-dependent drop in baseline tension, as seen with lactate (Figure 
4.12). The drop was significantly increased for concentrations ≥ 5mM propionate. When 
compared to the drop seen with lactate, there was no significant difference between the 
two weak acids (paired student t-test, p>0.05) 
The effect of propionate in the presence of oxytocin was also investigated. 1-20mM 
propionate was applied to tissue contracting under the stimulation of 0.5nm oxytocin 
(Figure 4.13 Ai-v). This response was the similar to lactate on oxytocin-driven activity. 
Frequency was significantly reduced at concentrations ≥10mM (paired students t-test, 
p<0.05), a.u.c. was significantly affected at 3mM, 10mM and 20mM propionate. Amplitude 
was only significantly affected in 3mM propionate. The EC50 value generated from a.u.c. 
data is 5.2mM ± 1.0mM (Figure 4.14). 
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Figure 4.10 Dose dependency of sodium propionate in pregnant human myometrium
A. Representative isometric recordings of spontaneously contracting myometrial strips 
during 20 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM and (v) 20mM 
propionate.
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Figure 4.11 Dose dependency of sodium propionate in pregnant human myometrium
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to propionate. N numbers are 
denoted by values within bars. A significant difference in activity was found using ANOVA 
with Bonferroni post-hoc test * denotes p<0.05.
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Figure 4.12 Drop of baseline tension in the presence of sodium propionate
A dose dependent drop in baseline tension of spontaneously contracting human 
myometrium in response to 1mM (blue bar) 3mM (red) 5mM (green) 10mM (orange) and 
20mM propionate (purple). N numbers are denoted by values within bars.
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Figure 4.13 Dose dependency of sodium propionate in oxytocin-driven activity
A. Representative isometric recordings of contracting myometrial strips in the presence of 
oxytocin during 5 minutes application of (i) 1mM (ii) 3mM (iii) 5mM (iv) 10mM (v) 20mM  
propionate.
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Propionate caused a significant baseline tension drop (Figure 4.15). This was significant in 
3mM, 10mM and 20mM propionate, in the presence of oxytocin. When compared to the 
drop seen in lactate in the presence of oxytocin, this was not significantly different. 
Mean data for lactate and propionate was plotted together to compare the two weak acid 
responses. There is no significant difference between lactate and propionate on 
spontaneous activity, in amplitude (Table 4.1 Ai), duration (Table 4.1 Aii), frequency (Table 
4.1 Aiii) or a.u.c. (Table 4.1 Aiv).  
There was also no significant difference in responses between propionate and lactate in the 
presence of oxytocin for all parameters (Table 4.2 Ai-iv).  
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Figure 4.14 Dose dependency of sodium propionate in oxytocin-driven activity
A. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) AUC in response to propionate. N numbers are denoted by 
values within bars. A significant difference in activity was found using ANOVA with 
Bonferroni post-hoc test * denotes p<0.05 **p<0.01 ***p<0.001 significance.
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Figure 4.15 Drop of baseline tension in the presence of propionate and oxytocin
A dose dependent drop in baseline tension of oxytocin-driven contracting human 
myometrium in response to 1mM (blue bar) 3mM (red) 5mM (green) 10mM (orange) and 
20mM propionate (purple). N numbers are denoted by values within bars.
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Table 4.1 A comparison of lactate and propionate response in spontaneous activity
A. Mean data ± s.e.m. showing dose-dependent decrease in (i) amplitude (ii) duration (iii) 
frequency and (iV) AUC in response to lactate, and propionate when applied to 
spontaneously contracting term pregnant non-labouring human myometrial strips. 20mM  
response was excluded in the tables as both abolished contractility. 
There was no significant difference between the two weak acids.
A
(i) (ii)
(iii) (iv)
Lactate Propionate P 
value
1mM 93.9±4.9% 86.7±5.9% 0.38
3mM 100.5±5.4% 88.4±4.7% 0.147
5mM 70.7±18.4% 52.4±23.5% 0.55
10mM 15.9±15.9% 35.3±22.3% 0.50
Lactate Propionate P
value
1mM 106.1±6.4% 90.0±5.7% 0.11
3mM 99.9±6.6% 90.9±5.3% 0.34
5mM 90. 8±7.6% 103.5±3.4% 0.41
10mM 100.9±0% 98.7±11.7% 0.96
Lactate Propionate P 
value
1mM 100±0% 80.2±10.7% 0.16
3mM 71.0±10.9% 75.7±10.2% 0.77
5mM 30.0±4.2% 25.0±14.7% 0.47
10mM 4.2±4.2% 26.4±12.1% 0.11
Amplitude Duration
Frequency AUC
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Table 4.2 A comparison of lactate and propionate response in oxytocin-driven activity
A. Mean data ± s.e.m. showing dose-dependent decrease in (i) amplitude (ii) duration (iii) 
AUC in response to lactate and propionate, when applied to term pregnant non-labouring 
human myometrial strips. There was no significant difference between the two weak acids.
A
(i)
(ii)
(iii) (iv)
Lactate Propionate P 
value
1mM 96.5±4.6% 92.3±0.7% 0.57
3mM 101.4±9.0% 86.9±3.4% 0.21
5mM 98.5±1.9% 87.2±7.5% 0.25
10mM 88.1±20.5% 58.6±25.4% 0.37
20mM 40.7±24.9% 0 0.25
Lactate Propionate P 
value
1mM 112.5±5.9% 101.5±2.6% 0.64
3mM 92.9±4.1% 77.0±18.9% 0.45
5mM 101.6±3.7% 97.4±6.6% 0.69
10mM 89.2±21.0% 99.2±4.4% 0.89
20mM 44.5±27.3% 0 0.90
Lactate Propionate P 
value
1mM 81.2±6.2% 100±0% 0.05
3mM 90.0±6.1% 75.0±10.2% 0.23
5mM 60.8±5.3% 66.7±11.8% 0.62
10mM 40.3±13.2% 35.8±16.3% 0.84
20mM 10.0±6.1% 0 0.19
Amplitude Duration
Frequency AUC
(ii)
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4.4.4 Non-pregnant myometrium 
The effect of 5mM sodium lactate on non-pregnant myometrium was determined. Lactate 
was applied for 20 minutes to spontaneously contracting myometrial strips (n=6) (Figure 
4.16 A). When compared to the preceding control period, there was a decrease in 
contractile activity (Figure 4.16 B). Amplitude decreased to 80.4% ± 16.2% (paired student t-
test, p=0.29) (Figure 4.16 Bi), duration significantly decreased to 83.1% ± 8.8% (p=0.03) 
(Figure 4.16 Bii), frequency to 55.1% ± 14.7% (p=0.08) (Figure 4.18 Biii) and a.u.c significantly 
decreased to 61.2% ± 14.4% (p=0.04) (Figure 4.16 Biv).  
Mean data from lactate’s effect on human term pregnant myometrium was compared to 
non-pregnant lactate response (Figure 4.17). There is little difference between amplitude 
(Figure 4.17 Ai) (students unpaired t-test, p=0.70) and duration (Figure 4.17 Aii) (p=0.53). 
There is a marked difference between frequency of contraction (Figure 4.17 Aiii) (p=0.48) 
and a.u.c (Figure 4.17 Aiv) (p=0.16). However these differences were not statistically 
significant.  
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Figure 4.16 The effect of sodium lactate on non-pregnant human myometrium
A. Representative isometric recordings of spontaneously contracting myometrial strips 
during 20 minutes application of  5mM sodium lactate on spontaneously-contracting non-
pregnant myometrium (n=6).
B. Mean data ± s.e.m. (denoted by error bars) showing dose-dependent decrease in (i) 
amplitude (ii) duration (iii) frequency (iv) AUC in response to 5mM lactate (red) when 
compared to the preceding control (blue). N numbers are denoted by values within bars. 
There was a significant difference in duration and a.u.c (students paired t-test, p= 0.03and 
p=0.047 respectively)
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Figure 4.17 Comparison of lactate response between non-pregnant and pregnant 
human myometrium
A. Mean data (i) amplitude (ii) duration (iii) frequency and (iv) a.u.c. of the response of 
5mM lactate in non-pregnant human myometrial tissue (red bar) and pregnant 
myometrium (green). There was no significant difference between the two gestational 
states.
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4.4.5. Comparison of rat and human lactate data 
As the same experimental procedures were used to test the effect of lactate on human and 
rat myometrium and both tissues were the same gestation (term non-labouring), I can 
directly compare the two tissues. Mean data for 1-20mM lactate on all four parameters of 
contractility for spontaneously contracting pregnant myometrium were plotted together 
(Figure 4.18) and statistical analysis between groups performed. The EC50 values for these 
two tissues were 3.9 ±0.3mM (rat) and 3.8 ±0.7mM (human). There was no significant 
difference between rat and human myometrium in amplitude (Figure 4.18 Ai) duration 
(Figure 4.18 Aii) frequency (Figure 4.18 Aiii) or a.u.c (Figure 4.18 Aiv) (Table 4.3) (Anova with 
Bonferroni post-hoc test, p>0.05). 
Mean data for rat and human pregnant myometrium in the presence of oxytocin was also 
compared (Figure 4.19). The EC50 values for these two tissues were 11.1 ±1.7mM and 5.4 
±1.2mM respectively. There was no significant difference between rat and human 
myometrium in amplitude (Figure 4.19 Ai) duration (Figure 4.19 Aii) frequency (Figure 4.19 
Aiii) or a.u.c (Figure 4.19 Aiv) (Table 4.4) (Anova with Bonferroni post-hoc test, p>0.05). 
Non-pregnant tissue when challenged with 5mM lactate, from both rat and human 
myometrium, was also compared (Figure 4.20). There was no significant difference between 
these two tissue types (Students unpaired t-test, p>0.05). 
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Figure 4.18 Comparison of lactate response between rat myometrium and human 
myometrium
A. Mean data for (i) amplitude (ii) duration (iii) frequency and (iv) a.u.c. comparing rat 
myometrium (purple) and human myometrium (turquoise) on spontaneously contracting 
tissue. There was no significant difference between the two tissues.
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Table 4.3 Comparison of lactate response between rat myometrium and human 
myometrium
A. Mean data for (i) amplitude (ii) duration (iii) frequency and (iv) a.u.c. comparing rat 
myometrium and human myometrium  on spontaneously contracting tissue. There was no 
significant difference between the two tissues. 20mM response was excluded from the 
table as contractions were completely abolished.
A
(i)
(ii)
(iii) (iv)
Rat Human P 
value
1mM 96±10% 93.9±4.9% 0.66
3mM 70±15% 100.5±5.4% 0.09
5mM 53±16% 70.6±18.4% 0.34
10mM 19±13% 15.9±15.9% 0.62
Rat Human P  
value
1mM 98.3±2.2% 106.1±6.4% 0.30
3mM 86.2±15.9% 99.9±6.6% 0.31
5mM 90.5±2.2% 90.7±7.6% 0.04*
10mM 65.3±9.1% 100.9±0% 0.05
Rat Human P 
value
1mM 97±1% 100% 0.08
3mM 84±14% 71.1±10.9% 0.42
5mM 43±12% 30.1±17.2% 0.69
10mM 36±13% 4.2±4.2% 0.31
Amplitude Duration
Frequency AUC
(ii)
Rat Human P 
value
1mM 84.1±11.2% 88.1±3.3% 0.74
3mM 62.6±14.1% 57.2±6.3% 0.78
5mM 35.5±12.9% 33.3±12.1% 0.92
10mM 14.5±9.7% 5.0±5.0% 0.43
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Figure 4.19 Comparison of lactate response between rat myometrium and human 
myometrium in the presence of oxytocin
A. Mean data for (i) amplitude (ii) duration (iii) frequency and (iv) a.u.c. comparing rat 
myometrium (purple) and human myometrium (turquoise) on  oxytocin-stimulated tissue. 
There  was no significant difference between the two tissues.
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Table 4.4 Comparison of lactate response between rat myometrium and human 
myometrium in the presence of oxytocin
A. Mean data for (i) amplitude (ii) duration (iii) frequency and (iv) a.u.c. comparing rat 
myometrium and human myometrium on oxytocin-stimulated tissue. There  was no 
significant difference between the two tissues.
A
(i)
(ii)
(iii) (iv)
Rat Human P 
value
1mM 96.7±0.8% 96.5±4.6% 0.61
3mM 95.0±1.9% 101.4±9.0% 0.65
5mM 75.6±19.1% 98.5±1.9% 0.63
10mM 69.5±14.2% 88.1±20.5% 0.17
20mM 30.4±21.5% 40.7±24.9% 0.99
Rat Human P  
value
1mM 94.7±4.1% 112.5±5.9% 0.31
3mM 93.5±2.0% 93.0±4.2% 0.40
5mM 74.0±18.5% 101.6±3.7% 0.17
10mM 66.6±13.7% 89.2±21.0% 0.69
20mM 29.9±23.3% 44.5±27.3% 0.20
Rat Human P 
value
1mM 105±1.5% 81.2±6.2% 0.23
3mM 104±4% 90.0±6.1% 0.85
5mM 69±22% 60.8±5.3% 0.09
10mM 74±24% 40.3±13.2% 0.23
20mM 43±30% 10.0±6.1% 0.25
Amplitude Duration
Frequency AUC
(ii)
Rat Human P 
value
1mM 94.9±3.0% 80.8±1.3% 0.18
3mM 80.7±7.3% 71.7±11.4% 0.27
5mM 68.5±17.3% 55.2±12.9% 0.38
10mM 48.3±15.9% 13.8±10.4% 0.16
20mM 20.9±19.3% 2.8±2.4% 0.41
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4.5 Discussion 
No previous functional study has investigated the effect of lactate on myometrial 
contractility. Previous work has indicated lactate may play a role in dysfunctional labour. 
This study shows that the application of lactate and another weak acid, propionate, cause a 
decrease in human myometrial contractility in a dose-dependent manner. This occurs in 
both spontaneously contracting tissue and in the presence of oxytocin, although oxytocin 
provides a ‘rescue effect’ as seen in the dose-response curve (which is shifted to the right). 
5mM lactate affects contractility in non-pregnant myometrium, but to a lesser extent than 
term pregnant tissue. 
I propose that lactate is affecting human myometrium in the same way as rat myometrium 
as suggested in Chapter 3. Although intracellular pH was not investigated using human 
tissue, it is likely to be the cause of its ability to decrease contractions, via its action on L-
type Ca2+ channels. The inhibition of these channels caused by intracellular acidification in 
human myometrium has already been shown (Pierce et al. 2003). Also women experiencing 
a dysfunctional labour have been shown to have a lower myometrial blood pH than women 
experiencing a normal labour (Quenby et al. 2004) indicating acidification. 
There was a notable drop in baseline tension when either lactate or propionate was applied, 
regardless of the presence of oxytocin. This may be due to the fact H+ and Ca2+ are cations 
and therefore there may also be competition between the two ions at intracellular binding 
sites. H+ could displace Ca2+ bound to myofilaments and therefore decrease tone. This loss 
of tension was not seen in rat myometrial tissue in Chapter 3.  However larger tissue strips 
from rat uterus that contain both circular myometrium and endothelium have been shown 
to lose tension when challenged with hypoxic conditions (Personal communication: Dr Sarah 
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Arrowsmith). Because of this the effect of weak acids on myometrial tissue may be 
underestimated in smaller strips as they have a smaller mass (and therefore the number of 
muscle bundles is significantly lower). 
Non-pregnant myometrium appears to be more resistant to the effect of 5mM lactate when 
compared to term pregnant human myometrium. Differences between the two gestational 
states could be responsible for this. There may be a difference in lactate transporters 
between non-pregnant and pregnant myometrium i.e. lower in non-pregnant myometrium 
and therefore in these experiments, less lactate could enter the myometrial cells. Cells in 
non-pregnant myometrium have not undergone hypertrophy which occurs during 
pregnancy. This may be the case as the non-pregnant myometrial strips are harder to 
dissect from biopsies than pregnant biopsies as the tissue is firmer, more compact and 
harder to blunt dissect. When lactate’s effect on human non-pregnant myometrium is 
compared with non-pregnant rat tissue, there is no significant difference between the two. 
This is good indication that the animal model is robust for future experiments. 
The effect of lactate on rat and human contractility was compared and no significant 
differences were found between the two. This is another good indication that the animal 
model is ideal for future lactate experiments. Although lactate in both tissues produced a 
dose-dependent decrease in contractility, there were slight differences between the two. 
Frequency of normal control contractions was lower in human tissue, hence the longer 
lactate application time. Amplitude and duration of contractions in human tissue are higher.  
These three parameters may be linked. Every care was taken to dissect tissue strips of 
similar size to avoid differences in contractility cause by differences in size. The dose 
response curve for lactate in human tissue stimulated by oxytocin was shifted further to the 
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right than rat tissue as indicated by the EC50 values. This shows the ‘rescue effect’ of 
oxytocin and why it is used in clinical practice as a treatment of dysfunctional labour. The 
concentrations of oxytocin were chosen as they have been used previously in myometrial 
contractility experiments I could speculate that at higher concentrations of oxytocin, lactate 
would be ineffective at decreasing contractility. However in vivo this may produce a large 
tonic contraction upon application. Other in vivo differences e.g. acidic extracellular 
environment and hypoxia may occur that would decrease the effectiveness of oxytocin. 
4.5.1 Limitations of study 
- This study has low n numbers. Human tissue is, in its nature, more variable than an 
animal model and the tissue is harder to acquire. My conclusions on the effects of 
lactate however appear to be robust as the effects are large and reproducible. More 
experiments would increase confidence in the conclusion between non-pregnant 
and pregnant myometrium. 
- No experiments were performed on labouring human myometrium therefore it is 
still unclear the effect of lactate on this tissue and how it relates to dysfunctional 
labour. 
- No mechanistic work looking at intracellular pH or Ca2+ was included in this study. 
These experiments need to be done to confirm the mechanistic action of lactate in 
human myometrium, although these have been performed for rat myometrium and I 
anticipate that the conclusions would be similar concerning mechanisms. 
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4.6 Summary 
Lactate has profound effects on the contractility of human myometrium. It caused a dose-
dependent decrease in contractility that was not overcome by the application of oxytocin. If 
lactate is involved in dysfunctional labour, this would correlate with clinical observations. 
There was no difference between lactates response in human or rat myometrium, indicating 
the animal model is robust to use for future experiments concerning lactate and 
mechanistic data obtained in rat myometrium would be comparable to human 
myometrium.  
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Chapter 5 
The expression of monocarboxylate transporters (MCTs) in 
rat and human myometrium 
5.1 Abstract 
Monocarboxylate transporters (MCTs) are responsible for transporting lactate and other 
monocarboxylates, including pyruvate and ketone bodies, across the plasma membrane. 
Monocarboxylates, together with a proton, are transported down the concentration 
gradient via MCTs 1 to 4. They are widely expressed in many tissues, including skeletal 
muscle, where it has been shown that MCT-4 is up-regulated in hypoxic conditions. There is 
limited evidence for the expression of MCTs in the myometrium. The aim of this study was 
to investigate the expression of MCT-1 and MCT-4 in both rat and human myometrium. 
Proteins were extracted from myometrium of rats throughout gestation, including non-
pregnant and labouring myometrium and human non-pregnant and pregnant myometrial 
tissue. Western blots were performed using anti-MCT-1 and anti-MCT-4 antibodies with 
anti-β-actin antibody used as an internal loading control. Experiments show that both 
transporters are present in rat and human myometrium. The levels of MCT-1 and MCT-4 
change throughout gestation of rat myometrium with MCT-1 being at its highest in mid-
gestation (n=2), and MCT-4 being at its lowest (n=4). Expressions of both transporters are 
higher in pregnant myometrium compared to non-pregnant tissue (n=4). A small 25kDa 
band was seen when probed with anti-MCT-4 antibody. Initial experiments agree with 
previous studies that MCT-1 and MCT-4 are present in the myometrium. It is the first study 
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to investigate their expression throughout gestation and compare with expression in non-
pregnant myometrium. Future work will determine the localisation of these transporters in 
the myometrium. 
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5.2 Introduction 
Monocarboxylates such as lactate, pyruvate and ketone bodies are involved in a number of 
metabolic pathways, including lipogensisis, gluconeogenesis, and anaerobic glycolysis. They 
are transported across the plasma membranes of cells by proton-linked monocarboxylate 
transporters (MCTs) (Halestrap 2012). 
MCTs are part of the solute carrier (SLC) 16 family. Out of a total of 14 family members, only 
four have been shown to facilitate proton-linked monocarboxylate transport: MCTs 1-4.  
The structure of MCTs is similar to other SLC16 family members and they share conserved 
sequence motifs (Halestrap & Meredith 2004) (Figure 5.1). The transporters consist of 12 
transmembrane helices with an intracellular N and C terminus. They first bind H+ followed 
by a lactate anion. There is a conformational change of the protein to a closed formation 
which exposes lactate and H+ to the opposite side of the membrane and the two molecules 
are released. This transport can be stimulated by a drop in cytoplasmic pH or increased pH 
on extracellular side, which decreases Km (defined as substrate concentration at half the 
maximum velocity) for lactate. 
Ancillary proteins are needed for the activity of MCTs on the cell surface. Embigin (GP70) 
and Basigin (CD147) both have a single transmembrane domain with a large glycosylated 
extracellular domain. These proteins need to be expressed for their respective MCTs to be 
expressed on the plasma membrane. If this does not happen, the transporters accumulate 
in the Golgi apparatus i.e. they act as a chaperone proteins (Halestrap & Wilson 2012). MCTs 
1 and 4 co-localise with Basigin, although MCT-1 will bind Embigin if there is no Basigin. 
MCT-2 can bind Basigin if there is no Embigin. 
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Figure 5.1 Monocarboxylate transporter-1 and its ancillary protein, Basigin
Monocarboxylate transporters (MCTs) consist of 12 transmembrane helices with an 
intracellular N and C terminus.  Ancillary proteins  (e.g. Basigin) are needed for the 
expression of these transporters on the plasma membrane.
MCTs bind H+ followed by a lactate ion. There is a conformational change which exposes 
lactate and H+ to the opposite side of the membrane.
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MCT- 1 is found in the majority of tissues across a wide range of species. It has been shown 
to be up-regulated in response to exercise in skeletal muscle, i.e. conditions when lactate 
may be anticipated to rise. (Halestrap 2012) 
MCT-4 is widely expressed in glycolytic tissue e.g. white skeletal muscle fibres and white 
blood cells. In the neonate heart, MCT-4 is dominant whereas in the adult heart there is no 
MCT-4. This is because it is less glycolytic than the neonate heart. MCT-4 is also strongly 
expressed in placenta to export lactate and H+ rapidly from fetal circulation to maternal 
blood. It has a high Km value for pyruvate (therefore low affinity) to avoid its loss from the 
cell. This prevents removal of NADH which is formed when pyruvate is converted to lactate 
and allows the continuation of glycolysis. 
MCT-2 is similar to MCT-1 as they both have higher affinities for pyruvate over lactate. 
However the tissue distribution of these two transporters is different (Garcia1995) and the 
capacity to transport these acids is lower in MCT-2 compared to MCT-1 (Broer1999). MCT-3 
is only found in retinal pigment epithelial cells (Halestrap & Meredith 2004). 
The only evidence for presence of MCTs in the myometrium is from Akerud et al 2009. This 
group used immunohistochemistry techniques on cultured myometrial cells from human 
pregnant myometrial biopsies. They found MCT-1 and MCT-4 to be present, at the cell 
membrane and in the stroma (MCT-4 only). MCT-4 was found at lower levels than MCT-1 
(Akerud, Ronquist & Wiberg-Itzel 2009).  
 The aim of this study was to investigate the expression of MCT-1 and MCT-4 in rat and 
human non-pregnant and pregnant myometrium, and in rat myometrium throughout 
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gestation. These transporters were chosen due to their proven role in exercise and lactate 
transport when glycolysis is increased. 
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5.3 Methods 
5.3.1 Tissue and protein extraction 
Myometrium was dissected from non-pregnant virgin rats, 11 day gestation, 18 day, 22 day, 
23 day and labouring rats. 23 day pregnant animals were due to deliver within 4 hours and 
were used to determine if expression of transporters change immediately prior to labour. 
Human myometrial biopsies, both non-pregnant and pregnant, were used. Non-pregnant 
samples were age (mean 44 years ±1year) and BMI-matched (28.7 ±0.5). Pregnant samples 
were closely matched by age (mean 32 years ±0years), BMI (22.4 ±1.4), gestation 
(39weeks+1day ±1day), parity (1 ±0) and reason for section (previous traumatic vaginal 
delivery). Four samples of non-pregnant tissue and pregnant tissue were selected, to 
indicate natural differences. Tissue strips were dissected and weighed and flash frozen in 
liquid nitrogen and stored at -80oC until sufficient samples had been collected for all 
experiments. Tissue from rat skeletal muscle, liver and brain were dissected and frozen for 
use as positive controls. Proteins were extracted in RIPA buffer using liquid nitrogen. Protein 
samples were quantified using Bio-Rad DC protein assay. Due to the low amount of protein 
in 3/8 human samples (2 non-pregnant, 1 pregnant), these were not used in experiments. 
25µg of protein was added to 3x Laemmli buffer (0.125M Tris-HCl pH6.8, 4% SDS, 20% 
glycerol, 0.004% bromophenol blue, 10% β-mercaptoethanol) and boiled for 3minutes. 
5.3.2 SDS_PAGE and Immunoblotting 
12% resolving gel and 4% stacking gel were cast using OMNI-Page kit. 20µl prepared protein 
was loaded. 5µL protein ladder (SeeBlue® Plus2 Pre-stained standard, Invitrogen) was also 
loaded to show efficient transfer and allow recognition of proteins. Gels were run at 120V 
for 2hours. Gels assembled into transfer cassettes with nitrocellulose paper and transferred 
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at 40V for 1 hour. Membranes were incubated in primary antibodies overnight at 4oc. After 
washed in TBS-0.1% tween for 40minutes, membranes were incubated in secondary 
antibodies for 1 hour at room temperature. After a further 1x15minute and 4x5minute 
wash, Membranes were incubated in chemiluminescent ECL reagent for Horseradish 
peroxidase (HRP) enzyme for 5 minutes (SuperSignal West Pico Chemiluminescent 
Substrate, Thermo Fisher Scientific). Negative controls were incubated overnight or for 1 
hour on Day 2 in 5% BSA.  Blots were quantified using Image J and presented at % of β-actin 
internal control expression. 
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5.4 Results 
5.4.1 Expression of MCT-1 
5.4.1.1 Rat myometrium 
To address the question of whether there are monocarboxylate transporters in the 
myometrium, western blotting using antibodies against MCT-1 was performed on rat 
myometrium to investigate its expression (Figure 5.2). Protein (25µg) from myometrium of 
rats at defined stages of gestation was used, along with skeletal muscle as a positive control. 
Due to the high amount of expression of MCTs in skeletal muscle, 12.5µg of this protein was 
loaded. This was taken into consideration during analysis. Figure 5.2 A shows a 
representative blot for MCT-1 (n=2). MCT-1 was detected in all of these tissues. There are 
two bands in skeletal muscle (Figure 5.2 A). Using the same experimental protocol and 
tissues, simultaneous blots were probed with anti β-actin antibody as a loading control. β-
actin is a highly conserved protein and a major constituent of contractile apparatus. Because 
of this it is a commonly used control and has been used and validated previously in my 
group. There was no significant difference between β-actin expression from the rat 
myometrium tested, indicating even protein loading (Students unpaired T-test, p>0.05). 
Densitometric quantification of MCT-1 expression was performed and displayed at 
percentage of β-actin internal control expression (Figure 5.2 B). Analysis of signal intensity 
shows there appears to be a small increase in expression towards mid-gestation which 
decreases in labouring tissue, to lower than non-pregnant levels. MCT-1 in skeletal muscle 
was 1572% times higher than in the myometrium. Due to the low n numbers for this 
experiment, statistical analysis was not performed on the signal intensity of MCT-1. 
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Figure 5.2 Presence of MCT1 in rat myometrium
A:  Representative image of blots for MCT1 in rat myometrium throughout gestation 
(n=2). 25µg protein was loaded for all gestations and positive controls, except skeletal 
muscle where 12.5µg was used.
B:  Quantification  of MCT1 expression. Densitometric quantification of western blots for 
all gestations, displayed as % of  matched β-actin internal control expression.
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5.4.1.2 Human myometrium 
As I had demonstrated that there was MCT-1 in rat myometrium, expression in human non-
pregnant and pregnant myometrium was tested. An initial experiment with MCT-1 antibody 
provided a positive result (Figure 5.3 A). However when the same experiment was repeated 
omitting the primary anti- MCT-1 antibody, the same bands were seen (Figure 5.3 B). This 
indicated the secondary antibody (goat anti-rabbit) was binding non-specifically to proteins 
in the samples and potentially obscuring true MCT-1 expression. Another secondary 
antibody, donkey anti-rabbit, was used and this provided a cleaner blot with no bands seen 
(Figure 5.3 C)  
Figure 5.4 A shows a representative blot for MCT-1 in human myometrium (n=4). MCT-1 was 
detected in both non-pregnant and pregnant tissues. Using the same experimental protocol 
and tissues, simultaneous blots were probed with anti β-actin antibody as a loading control. 
There was no significant difference between β-actin expression (Students unpaired T-test, 
p>0.05) 
Quantification of MCT-1 expression in human myometrium was performed and displayed at 
percentage of β-actin internal control expression (Figure 5.4 B). There is an increase in signal 
intensity in pregnant tissue when compared to non-pregnant tissue, but there was no 
significant difference between the two tissue types (p=0.35). 
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Figure 5.3 Non-specific binding of the secondary antibody in human myometrium
A: Representative western blot probed with anti- MCT-4 antibody. Bands are seen at 
expected kDa weight.
B: Control western blot probed with secondary goat anti-rabbit antibody. Bands are seen 
are expected kDa size of MCT proteins.
C: Control western blot probed with secondary donkey anti-rabbit antibody. No bands are 
seen at MCTs expected size. 
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Figure 5.4 Presence of MCT1 in human myometrial tissue
A:  Representative image of blots for MCT1 in human non-pregnant and pregnant 
myometrium (n=4). 25µg protein was loaded for all gestations and positive controls (brain 
and liver)
B:  Optical density of MCT1, displayed as % of  matched β-actin control.
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5.4.2 Expression of MCT-4 
5.4.2.1 Rat myometrium 
MCT-4 expression in rat myometrium through gestation was investigated (Figure 5.5) Figure 
5.5 A shows a representative blot for MCT-4 in rat myometrium (n=4). MCT-4 was detected 
in all tissues; non-pregnant, 11 day, 18 day, 22 day and 23 day gestation and labouring 
tissue. Rat skeletal muscle was used as a positive control for the antibody. There are two 
bands at the expected molecular weight of MCT-4 (45 kDa). Using the same experimental 
protocol and tissues, simultaneous blots were probed with anti β-actin antibody as a loading 
control. There was no significant difference between β-actin expression (Students unpaired 
T-test, p>0.05) 
Quantification of MCT-4 expression was performed and displayed at percentage of β-actin 
internal control expression (Figure 5.5 B). Initially the intensity of both bands was combined 
to give one single reading for each gestation. There is a decrease in signal as the 
myometrium increases in gestation. There is a small increase in 23 day pregnant 
myometrium and a bigger increase when the tissue is labouring. This is larger than the signal 
for non-pregnant tissue. Despite the change, there was no significant difference between 
the different tissues (p>0.05). 
As there were two distinct bands, separate analysis was performed to see if the bands 
changed throughout gestation. The intensity of the higher weight band (defined ‘Top band’) 
was compared against the intensity of the lower band (‘Bottom band’) as a percentage of 
total band intensity (Figure 5.6). The bottom band in non-pregnant and 11 day myometrium 
is higher than the bottom band and this pattern shifts in 18 day onwards- top band has a 
higher intensity than the bottom band.  
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Figure 5.5 Presence of Monocarboxylate transporter 4 (MCT4) in rat myometrium
A:  Representative image of blots for MCT4 in rat myometrium throughout gestation 
(n=4). 25µg protein was loaded for all gestations and positive controls, except skeletal 
muscle where 12.5µg was used.
B:  Optical density of MCT4, displayed as % of  matched β-actin control.
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Figure 5.6 Quantification of multiple bands of MCT4 in rat myometrium
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5.4.2.2 Human myometrium 
The expression of MCT-4 was examined in human myometrium (n=4) (Figure 5.7). At the 
predicted molecular weight, there were no bands in either non-pregnant or pregnant 
samples. A band was seen in skeletal muscle, the positive control (Figure 5.6 A). Bands were 
seen at 25kDa in all three pregnant samples (Figure 5.7 A, red circle). Simultaneous blots 
were probed with anti β-actin antibody as a loading control and there was no significant 
difference between β-actin expression (Students unpaired T-test, p>0.05). 
Quantification of MCT-4 expression in human myometrium was performed and displayed at 
percentage of β-actin internal control expression. The area of predicted molecular weight 
was analysed and there was no increase in signal intensity. When comparing that result for 
non-pregnant myometrium to the lower weight bands seen in pregnant myometrium 
(Figure 5.7 B) there is an increase in signal intensity in pregnant tissue. This difference in 
signal intensity between the two samples was significant (p=0.006). 
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Figure 5.7 Presence of MCT4 in human myometrial tissue
A:  Representative image of blots for MCT4 in human non-pregnant and pregnant 
myometrium (n=4). 25µg protein was loaded for all gestations and positive controls, 
except skeletal muscle where 12.5µg was used.
B:  Optical density of MCT4, displayed as % of  matched β-actin control.
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5.5 Discussion 
There is little previous evidence for the expression of monocarboxylate transporters in the 
myometrium, as only one previous study appears to have been published. One study has 
shown, by immunohistochemistry that MCTs 1 and 4 are present in cells for pregnant 
myometrial biopsies but their expression was not quantified or expression throughout 
pregnancy investigated. The aim of this study was to investigate MCT expression in both rat 
and human myometrium. Initial experiments have indicated that both transporters are 
present and are expressed at varying levels from non-pregnant myometrium throughout 
gestation and in term and labouring myometrium. 
β-actin expression was used as an internal loading control and in the experiments 
performed in this study; the expression in the myometrium was not significantly different 
between samples. This indicates protein loading was even throughout experiments and that 
any differences seen in MCT signal intensity was not be due to protein loading. Levels of β-
actin were higher in myometrium compared to skeletal muscle. This is because skeletal 
muscle expresses α-actin. 
Bands corresponding to MCTs ran at a lower weight to their predicted molecular weight. 
This has been noted before in the literature (Hussien & Brooks 2011). Post-translational 
modifications can occur and if the protein has a higher molecular weight than predicted, this 
could be due to glycosylation, phosphorylation or multimer formation.  Proteins may be a 
lower molecular weight due to cleavage or degradation. 
When the anti-MCT-1 antibody used, multiple bands were detected at different molecular 
weights. This could be due to the fact “tissue extracts tend to contain more background 
bands and degradation products than cell line extracts due to connective tissue” (Cell 
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Signalling). The data sheet supplied with the antibody also detected other bands. Multiple 
bands may also indicate non-specific binding of either the primary or secondary antibodies. 
As in the case of human myometrium, the initial secondary antibody used (goat anti-rabbit) 
used showed bands at ~50kDa where MCTs 1 and 4 were expected to be. This non-specific 
binding has also been noted in other western blots in our laboratory using human protein 
samples and this secondary antibody (Personal communication: Dr. Sarah Arrowsmith). A 
different secondary antibody, donkey anti-rabbit, did not bind non-specifically. The reason 
for this result is unclear and requires further investigation. The antibody was not previously 
adsorbed with human proteins, which can cause non-specific binding in human protein 
samples.  
Double bands were seen in rat myometrium when probed for MCT-4. The intensity of two 
bands changed throughout pregnancy. The reason for this is unknown but it could be due to 
phosphorylation of protein. This would cause the protein to run at a higher molecular 
weight that un-phosphorylated protein.  Immunoprecipitation could be performed on these 
samples using the anti-MCT-4 antibody and then probed using phospho-ser- or thr- 
antibodies. This would determine if the protein is phosphorylated. 
In pregnant human myometrial samples, a small 25kDa band was seen when blots probed 
for MCT-4. It is half the size of normal MCT-4 protein (~50kDa) and was an unexpected 
result. However this has been seen before in a breast cancer cell line when probed with the 
same antibody (Hussien & Brooks 2011). Unfortunately there has been no other information 
published.  One reason for this smaller band could be alternative splicing of the MCT-4 gene 
which may influence the structure and function of the gene.  
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Akerud found MCT-4 in two locations in the myometrium (cell membrane and stroma). 
Although not using the same antibodies or same protocol, the two bands could correlate to 
the two separate locations. The difference in size could be due to a ‘tag’ that targets the 
transporter to a specific location. 
The use of anti-MCT-1 antibody on rat myometrium proved tricky, hence the low n number 
for this experiment. This was due to antibody (and the secondary antibody) not being fully 
optimised in this tissue type, despite several months of work. Further repeat experiments 
are needed to optimise these antibodies. 
Little difference in MCT expression was seen between 22 day and 23 day pregnant tissue. 
This demonstrates that changes in expression occur in mid-gestation, whether the protein is 
up regulated (MCT-4) or down regulated (MCT-1). Utilising this animal model, myometrium 
from every day of gestation could be tested for MCT expression which would give a clearer 
idea of when these changes occur and in what quantity.  
 
5.5.1 Limitations of study 
- The expression of transporters was not investigated for labouring or dysfunctionally 
human myometrium. It is interesting to speculate how their expression and localisation may 
be different compared with non-labouring myometrium. 
- The anti- MCT-1 antibody not fully optimised as multiple bands were seen on the blots. 
Further repeat experiments are needed to optimise the antibody in both rat and human 
tissue.  
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5.6 Summary 
This is the first body work to show the expression of MCT-1 and MCT-4 in rat myometrium 
at defined stages of gestation. My work suggests they are expressed and play an important 
role in the myometrium. This is in agreement with initial experiments using the inhibitor 
alpha-cyano-4- hydroxycinnamate. I believe they will be physiologically important when 
lactate rises within the myometrium and there may be decreased expression of these 
transporters within the myometrium of women labouring dysfunctionally. It would be useful 
to look at the expression of the accessory proteins that chaperone the transporters to 
analyse their involvement during pregnancy and in labour. 
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Chapter 6 
Final discussion 
 
The aim of this work in this thesis was to investigate the effect of 
lactate on myometrial contractility and to explore the mechanism 
by which it occurs. The ultimate aim is to understand what occurs 
during dysfunctional labour: how it is different from normal labour 
and thus modulate the process to improve outcomes for both 
mother and baby.  I believe the work described here goes some 
way to help us understand what may be affecting contractility in 
these labours. 
6.1 Lactate and pH 
This is the first functional study of the effect of lactate on myometrial contractility. In both 
human myometrial tissue and in an animal model, lactate reduced contractile activity in a 
dose-dependent manner. Comparison of the two tissue responses showed there was no 
significant difference between the two, indicating that the animal model is representative of 
human myometrium. To investigate its mechanism of action using the animal model, tissue 
strips were loaded with the pH-sensitive indicator Carboxy-Snarf AM. This allowed me to see 
lactate decreasing pHi of the myometrium. There is conflicting data in the literature about 
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lactates ability to cause a pH decrease (Brooks 2010). In some studies it is reported to 
alkalinise pH of the cell by buffering protons and leaving the cell via its transporters (Brooks 
et al. 2006). The pH measurements and null experiments performed in this study confirm 
that lactate is decreasing pH in the myometrium, and by using a weak base to ‘null’ the pH 
change, the effect on contractility is overcome. The use of butyrate, another weak acid that 
is commonly used in pH studies, produced the same effect on pHi and contractility as 
lactate. Labouring myometrium loaded with Carboxy-Snarf AM demonstrated that the drop 
in pHi when lactate is applied is less compared to term pregnant myometrium.  This suggests 
it is likely that the buffering capacity of human labouring tissue is increased.  This is turn 
suggests an adaptation, probably to cope with increased metabolites and protons due to 
increased work and metabolism during labour. It is interesting to speculate this may be a 
difference that occurs in dysfunctional labour: i.e. the buffering capacity is reduced and 
therefore unable to resist the effect of increased lactate (and H+). 
My data showing acidification and its effect on contractility correlates with previous 
studies that have shown intracellular acidification of the myometrium decreases 
contractility (Wray et al. 1992). It should be noted however that the lactate molecule itself 
may have an effect on the myometrium and the effect of pH on contractility may be 
masking this effect. It has been seen that lactate per se can affect chloride channels in 
skeletal muscle (de Paoli et al. 2010). 
6.2 Effects of H+ on the myometrium 
The effects of H+ on the pregnant myometrium have been previously documented. The 
reason for lactates effect on term pregnant tissue could be an in-built mechanism to 
prevent powerful tonic-like uterine contractions during labour, which could clamp down 
208 
 
blood vessels and reduce blood flow (and therefore oxygen) to the fetus and cause fetal 
distress. My data indicates H+ acts upon Ca2+ entry to the myometrial cell and may affect the 
contractile apparatus, as shown by the drop in baseline tension in human tissue samples.  
Throughout gestation the effect of lactate (and therefore H+) increased. It had little 
effect on non-pregnant myometrium. It is known Ca2+ channels increase towards parturition 
(Mershon, Mikala & Schwartz 1994) and as experiments using Ca2+ indicator Indo-1 AM has 
shown, H+ can affect L-type Ca2+ channels (Pierce et al. 2003). Intracellular pH of human 
myometrium is known to increase towards late pregnancy; non-pregnant myometrium is 
more acidic pHi than late-pregnant (Parratt, Taggart & Wray 1995a). Perhaps non-pregnant 
myometrial tissue is able to cope with acid load as already acidic? There is a change in 
intracellular conditions during pregnancy meaning it is less likely to cope with an acid load 
and that this is reversed in labour, where lactate also has little effect on contractility. 
Oxytocin is used to augment uterine contractions and it works to increase [Ca2+]i 
available for the excitation-coupling pathway.  The administration of oxytocin does not 
overcome lactate’s inhibitory effects on contractility. This indicates the increase in Ca2+ by 
oxytocin is not enough to continue contractions. This correlates to clinical observations 
where administration of oxytocin for dysfunctional labour does not increase the incidence 
of vaginal delivery (Bugg, Siddiqui & Thornton 2013). 
6.3 Lactate and MCTs 
This is the first known study investigating the expression of monocarboxylate transporters 1 
and 4 throughout gestation and in non-pregnant tissue. The results from this study correlate 
with other published studies (Akerud, Ronquist & Wiberg-Itzel 2009; Fishbein, 
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Merezhinskaya & Foellmer 2002). How does it correlate lactates response? There is not 
enough evidence to suggest if a change in expression of transporters is affecting 
contractility. It is an interesting result in double bands of MCT-4 in rat tissue and small band 
in human pregnant tissue. In some studies, two bands for MCT-1 and MCT-2 are seen in 
cattle but not MCT-4 (Koho et al. 2008).  
6.4 Dysfunctional labour 
The direct link between lactate and dysfunctional labour still needs to be established even 
though higher lactate levels have been seen in dysfunctionally labouring women in vivo 
(Quenby et al. 2004).The lack of human labouring and dysfunctionally-labouring myometrial 
samples makes this difficult. Rat myometrium is more readily available and the experiments 
in this thesis show that it generally behaves in a similar way to human myometrium. 
Although it is reasonable to extrapolate the labouring data to human myometrium, there 
may be species differences that are not obvious when comparing in non-pregnant or 
pregnant tissue. There is also no animal model for dysfunctional labour, only ‘normal’ 
labouring. Analysis of dysfunctionally-labouring samples is imperative to confirm the link 
between lactate and problematic labours. Preliminary data with Dr Annabelle Kendrick 
suggests lactate does have an effect on labouring myometrium. 
The clinical approach to treat dysfunctional labours is to augment uterine contractions 
using an agonist. If dysfunctional labour is caused by increased lactate in the myometrium, 
the agonist will need to overcome the effects of acidification that occur. In this study 
oxytocin was unable to overcome this effect indicating it is unsuitable for treatment of these 
labours. It has already been shown to be ineffective in clinical practice where it does not 
reduce the number of caesarean sections needed, although commonly recommended and 
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used. The pH null experiments in this thesis are promising as the addition of a weak base 
reduced the effect of lactate and normal contractions resumed. However the idea of using a 
weak base to ‘null’ the effect of the weak acid is long way from clinical practice as key 
considerations, such as how to get the base into the myometrium and how to avoid it 
having detrimental effects on the mother and baby, need to be considered and resolved.   
6.5 Future work 
6.5.1 Lactate generation 
Exploring lactate generation in the myometrium is fundamental to understanding the 
mechanism behind its action. With the use of a colorimetric assay, lactate generation can be 
determined in contracting myometrial tissue strips. Differences in lactate generation 
between labouring and dysfunctionally labouring myometrium in response to oxytocin 
stimulation and hypoxia would shed light on these problematic labours and offer insight into 
new treatments. Initial experiments using the assay shows lactate is produced in increasing 
quantities when challenged with oxytocin, possibly as it is contracting more forcefully and 
there are therefore longer periods of hypoxia, reducing lactate clearance. 
Preliminary results using this technique with Dr Annabelle Kendrick have shown 
higher levels of lactate are released from human labouring myometrium under oxytocin 
stimulation compared to spontaneous activity (Figure 6.1). However there was not enough 
time to investigate this fully. 
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Figure 6.1: Lactate assay standard curve 
 
 Lactate assay standard curve (red line) plotted using [lactate] efflux from human 
labouring myometrium under different contractile conditions: no oxytocin, 0.5-1nM 
oxytocin and 10nM oxytocin. 
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6.5.2 Lactate and MCTs 
Further investigation into MCTs is needed. qRT-PCR could be used to measure gene 
transcription and protein synthesis by mass spectrometry to establish if levels of the mRNA 
transcript for the transporters are altered or if only protein translation is changed in 
dysfunctionally labouring women. Determination of the MCTs location in myometrial cells is 
also vital: their location may change through gestation or when labour commences. Also it is 
vital to look at the chaperone proteins Embigin/Basigin to analyse their regulation during 
pregnancy and labour, and if they are altered in problematic labours. 
LDH enzyme expression has never been quantified in labouring human myometrium. 
Variation in expression may lead to a difference in lactate production between myometrial 
samples and be accountable for higher lactate levels seen in women with dysfunctional 
labour. Analysis of expression would shed more light on the differences that predispose to 
slow, inefficient uterine contractions. 
Gene expression profiling allows the measurement of expression levels of a large 
number of genes simultaneously. This technique could be employed to compare gene 
expression between ‘normal’ labouring and dysfunctionally labouring myometrium and 
could identify new genes that have yet to be investigated and may contribute to 
problematic labours. 
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